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Acronyms and Abbreviations 
ART antiretroviral treatment
ARV antiretroviral 
EFG European HIV/AIDS Funders Group
EMTCT elimination of mother-to-child transmission (also known as vertical transmission)
FCAA Funders Concerned About AIDS 
Global Fund Global Fund to Fight AIDS, Tuberculosis and Malaria 
GMT Gay men, other men who have sex with men, and transgender individuals
LGBT Lesbian, gay, bisexual, and transgender 
MSM men who have sex with men 
NHAS U.S. National HIV/AIDS Strategy 
PLWHA people living with HIV/AIDS
R&D research and development
SRHR sexual and reproductive health and rights
STI sexually transmitted infection
TA technical assistance 
TasP treatment as prevention
UNAIDS Joint United Nations Program on HIV/AIDS 
WCE Western and Central Europe
Note: All figures marked $ are U.S. dollar amounts. 
Please visit the FCAA website at www.fcaaids.org/resourcetracking for the resource tracking toolkit, including: a 
press release; the report methodology and survey tool; info on in-kind donations and technical assistance; and the websites, 
geographic focus, and past giving levels of all the top HIV/AIDS funders in 2011 identified in this report.
EXECUTIVE SUMMARY & ABOUT THIS REPORT












This resource tracking report on philanthropic support to  
HIV/AIDS from U.S.- and European-based funders in 2011 relies 
largely on surveys completed by funders, with supplemental 
review of data from grants databases and funders’ grants lists. 
Data was obtained for over 300 funders who are believed to 
represent the substantial majority of private philanthropic  
HIV/AIDS funding from the U.S. and Europe. 
Combined funding1 to address HIV/AIDS from both U.S. 
and European private philanthropic institutions totaled 
$644 million2 in 2011, a 5% increase over 2010. 
Among U.S.-based funders, total disbursements for  
HIV/AIDS reached $491 million in 2011. Increased funding  
from the Bill & Melinda Gates Foundation (which represented 
half of all total U.S.-based disbursements) and a few other  
top funders (such as M•A•C AIDS Fund and ViiV Healthcare) 
led to a small increase in overall funding from 2010 to 2011 (3%). 
The majority of U.S.-based funders, however, decreased funding 
to HIV/AIDS, including several top 10 funders that funded other 
health areas. Total disbursements from all funders other than the 
Gates Foundation were 5% lower in 2011 than 2010. 
Among European-based funders, the 2011 total disbursements 
reached $170 million, the highest point since 2007, when data 
was first reported consistently. The majority of European-based 
funders increased funding between 2010 and 2011, with funding 
rising 12% between the two years. Some of this increased funding 
in 2011, however, results from yearly fluctuations in grantmaking, 
rather than from the growth of new or existing programs. 
Both U.S. and European funders reported that their disbursements 
for HIV/AIDS would likely stay relatively flat over the next year. 
EXECUTIVE SUMMARY
Funders Concerned About AIDS (FCAA) and the European HIV/AIDS 
Funders Group (EFG) share the common mission of mobilizing philanthropic 
leadership, ideas, and resources to address the HIV/AIDS pandemic – 
domestically and internationally – as well as its social and economic 
consequences. Through this resource tracking effort, FCAA and EFG have 
been monitoring the field of HIV/AIDS philanthropy for close to a decade.
1 Unless otherwise specified, funding refers to disbursements, or money paid out in the given year.
2 Though total philanthropic disbursements for HIV/AIDS in 2011 amounted to $491 million from U.S.-based funders and $170 million from European-based funders, 
which adds up to $661 million, $17.4 million was deducted from the combined total to avoid double-counting of grants that were given between U.S. and European-
based funders and re-granted in 2011. 
KEY FINDINGS ON U.S. PHILANTHROPIC FUNDING FOR HIV/AIDS
Total funding in 2011: HIV/AIDS disbursements from 274 U.S.- based philanthropies totaled $491 million in 2011, amounting 
to 5,561 HIV/AIDS-related projects and grants.3  
Small increase from 2010-2011 led by three top 10 
funders: Among U.S.-based funders for which FCAA has 
two years of comparable data (2010 and 2011), disbursements 
for HIV/AIDS increased, but only by 3%, or $11 million ($449 
million in 2010 to $460 million in 2011). Significant increases in 
disbursements for HIV/AIDS from a few of the top 10 funders 
in 2011, including the Gates Foundation (which represented 
half of all total U.S.-based disbursements), M•A•C AIDS Fund 
and ViiV Healthcare, were largely offset by a disturbing trend 
of reductions by the majority.
Majority of funders decreased funding to HIV/AIDS 
from 2010-2011: Over 60% of top funders saw decreases in 
funding for HIV/AIDS from 2010 to 2011. Funding decreased 
by 5% (from $234 million in 2010 to $223 million in 2011) 
among funders other than the Gates Foundation, for which 
FCAA has two years of data. This included decreased funding 
from three top 10 funders in 2010 that indicated that their  
HIV/AIDS funding would decrease in 2011 due to a shift of 
funds to other related health areas, such as sexual and repro-
ductive health and rights, neglected diseases, chronic hunger 
and malnutrition, and maternal and child health.
Funding remains highly concentrated among top 10 funders: The top 10 funders accounted for 80% (or $392 million)  
of all HIV/AIDS-related disbursements in 2011. The Gates Foundation alone accounted for 49%. 










3 This includes data from 18 “top funders” in 2011 (those giving over $300,000) that were not included in the report on 2010 funding because either FCAA was not able 
to obtain their financial data (13 funders) or their funding increased to above $300,000 from 2010 levels (five funders). Of the 13 top funders that were missing in 2010 
due to lack of data, none were new to funding the HIV/AIDS response; these funders likely supported HIV/AIDS in 2010 but their data was not available.
4 Funding from individuals represented the majority of all charitable contributions in the U.S. at 73%, or $218 billion. Source: Giving USA Foundation. Giving USA 2012: 
The Annual Report on Philanthropy for the Year 2011, Executive Summary. 2012.
KEY FINDINGS ON U.S. PHILANTHROPIC FUNDING FOR HIV/AIDS
Few new funders entering the field of HIV/AIDS philanthropy: While the list of top funders (those giving $300,000 or 
more) in 2011 includes 18 organizations that were not included in 2010,3 when adjusted for missing data, the resulting number 
of top funders in 2011 is similar to that of 2010. Five organizations increased their 2010 funding levels to above $300,000 in 2011, 
but only one organization appears to be new to funding the HIV/AIDS response in 2011. 
2012 forecasted to remain the same: Almost half (45%) of funders that shared their anticipated grantmaking for 2012  
(49 of 69) forecast funding for HIV/AIDS would stay about the same compared to 2011, including the highest funder, the  
Gates Foundation, and four other top 10 funders.
Corporate funders play a key role: Fifteen corporate foundations and giving programs – including six of the top 10 funders 
– represented 26% (or $127 million) of total U.S. HIV/AIDS philanthropy for 2011, and about half of the total disbursements from 
funders other than the Gates Foundation. Comparatively among general philanthropy, corporate funders represent only 5% (or 
$14.5 billion) of total charitable giving in the U.S.4 
Majority of funding was directed to projects with a global aim: Projects that target a worldwide population (such as 
research) received the highest amount of funding in 2011, representing 44% (or $221 million) of all disbursements. This was fol-
lowed by funding to specific countries and regions outside of the U.S., which accounted for 36% ($179 million), while about 20% 
(or $98 million) was directed toward the domestic U.S. epidemic. 
Funding with a global aim: Research 
projects received nearly all of the fund-
ing with a global aim ($186 million), and 
medical research teams and projects (on 
such areas as vaccine development and 
basic HIV science), women, men who 
have sex with men, and youth were the 
top target populations.
Funding to specific countries and 
regions outside of the U.S: East & 
Southern Africa received the most fund-
ing of all regions outside the U.S. ($69 
million), followed by South Asia & the 
Pacific ($40 million), and East Asia & 
Southeast Asia ($22 million). Prevention 
projects received the biggest share  
($53 million), followed by treatment  
($30 million), and research ($28 million), 
while women, youth, and orphans  
and vulnerable children were the top 
target populations.
U.S. domestic funding: The Northeast 
and the South both received about  
$28 million in 2011, and were the U.S. 
domestic regions that received the  
highest share of funding in 2011.  
Prevention projects received the biggest 
share of U.S. domestic funding ($23  
million), followed by treatment ($21  
million), and social services ($21 million), 
while African Americans, men who have  
sex with men, women, and homeless/ 
impoverished persons were the top  
target populations.












KEY FINDINGS ON EUROPEAN PHILANTHROPIC FUNDING FOR HIV/AIDS
Total funding in 2011: HIV/AIDS disbursements from 38 European-based philanthropies totaled €138 million ($170 million)  
in 2011,5 amounting to 4,231 HIV/AIDS-related projects and grants. 
2011 highest funding yet: Among European-based funders 
for which EFG has five years of comparable data (2007-2011), 
disbursements for HIV/AIDS hit the highest point at €108 
million ($134 million) in 2011, compared to €84 million ($104 
million) in 2007. 
Increase from 2010 to 2011 among majority of funders: 
Among European-based funders for which EFG has two  
years of comparable data (2010 and 2011), disbursements for 
HIV/AIDS increased by €14 million ($17 million), or about 12%. 
Over 60% of these funders increased funding to HIV/AIDS 
between 2010 and 2011, including eight of the nine top 10 
funders for which two years of data were available. Several of 
these funders’ higher totals in 2011 resulted from the pay-out 
of two years of disbursements in one year, or other logistical 
fluctuations in yearly grantmaking, rather than resulting from 
the growth of new or existing programs.
Funding is highly concentrated among top 10 funders: The top 10 funders accounted for 82% (€117 million, or $144  
million) of all HIV/AIDS-related disbursements in 2011. 
2012 forecasted to remain the same: Almost half (44%) of the funders that answered this question forecast anticipated  
funding for HIV/AIDS would stay about the same in 2012 compared to 2011, including four top 10 funders. Several funders, 
including one top 10 funder, indicated that their HIV/AIDS disbursements would decrease in 2012 due to a shift of funds to  
other related health areas.
Majority of funding for countries or regions outside of Western and Central Europe, or projects with a global  
aim targeting a worldwide population: Approximately half of all funding in 2011 was directed to projects in specific  
countries and regions outside of the Western and Central Europe region (€74 million, or $92 million). About a third of all  
funding (€49 million, or $61 million) went to projects benefiting a global population, while €17 million ($21 million), or 12%  
of all funding in 2011, was expended on HIV/AIDS efforts benefiting countries in Western and Central Europe. By region,  
East & Southern Africa received the most funding (47%), followed by Western & Central Europe (18%). 
By category of intended use, the largest amount of funding 
went to research (€54 million, or $67 million), followed by 
prevention (€28 million, or $34 million).
The top three target populations of funding in 2011 were  
orphans and vulnerable children, youth, and women.
5 This includes data from nine funders in 2011 that were not included in the report on 2010 funding because EFG was not able to obtain their 2010 financial data (eight 
funders) or they were new to funding the HIV/AIDS response (one funder). The others are funders that likely supported HIV/AIDS in 2010 but whose data not available.










This year, 2012, marks the 25th anniversary of Funders Concerned About  
AIDS (FCAA), and the 10th anniversary of the European HIV/AIDS Funders 
Group (EFG). In commemoration, FCAA and EFG are proud to offer a new 
approach to resource tracking: one publication to bring together data on 
U.S.- and European-based HIV/AIDS philanthropy. This work is part of a 
joint effort of FCAA, EFG and UNAIDS to present a comprehensive portrait 
of global philanthropic HIV/AIDS resource flows.
Moving the Needle
Private funding has catalyzed development of effective 
interventions and held governments accountable for scaling them 
up. Advocacy to focus on vulnerable populations marginalized 
and even criminalized by their governments (such as men who 
have sex with men, people who inject drugs, and sex workers) 
has been fueled primarily by private funding. 
But what drives AIDS-related philanthropy today? How are 
private funders reacting to and organizing around key changes  
in data and policy? Where is our sector headed?
In an effort to help us begin to answer these questions, this report:
1.  Offers more examples of efficient, innovative and 
impactful funding. This year’s report features more than 
40 brief funding examples, with a special focus on the top 10 
funders for both FCAA and EFG.
2.  Includes a ‘Finding the Gaps’ component that uses the 
latest epidemiological data to highlight the needs of specific 
populations, regions, issues, and tactics (see right).
3.  Shares how funders are beginning to address key issues such 
as: the U.S. National HIV/AIDS Strategy, treatment as 
prevention, the UNAIDS Investment Framework, and 
supporting the Global Fund to Fight AIDS, Tuberculosis 
and Malaria.
4.  Explores the important integration of HIV/AIDS with 
other issues areas (such as reproductive health and rights, 
gender equality, and issues affecting LGBT communities). 
FINDING THE GAPS
In the U.S.:
U.S. South (see page 23)
Linkages To Care (see page 28)
Harm Reduction (see page 28)
Black Americans and Men Who Have  
Sex with Men (see page 32)
Worldwide:
Resource Needs by Geographic Area (see page 35)
Resource Needs by Category (see page 37) 
Elimination of Mother to Child Transmission  
(or Vertical Transmission, see page 40)
Treatment (see page 40)
Key Populations at Higher Risk: Sex Workers,  
People Who Inject Drugs, and Men Who Have  
Sex with Men (see page 44)
People Living with HIV, New Infections and Treatment 
Coverage by Geographic Area (see page 65)
Advocacy for Key Populations at Higher Risk  
(see page 70)
Specific Needs of Women (see page 72)
At the Crossroads
After decades of scaling up both private and public investment 
in HIV research, prevention, care, treatment and human rights 
protections, we now find ourselves in an era of stalled growth of 
resources. Only through sustained efforts and increased funding 
can we hope to reach an AIDS-Free generation.
We hope this report gives you the opportunity to reflect on the 
story and impact behind the numbers, and drives the critical 
conversations on where and how our sector can best innovate, 
strengthen, and advance the response. 
Thank you to the organizations that participated in this and 
previous year’s reports. We welcome, and look forward to, input 
from readers about how to improve future editions of U.S. & 
European Philanthropic Support to Address HIV/AIDS.
John Barnes, Executive Director, Funders Concerned About 
AIDS (FCAA)
Daniel Jae-Won Lee, Executive Director, Levi Strauss 
Foundation; and FCAA Board Chair
Peter McDermott, Managing Director, Children’s Investment 
Fund Foundation UK; and Interim Chair, European HIV/AIDS 
Funders Group (EFG)
Ton Coenen, Executive Director, Aids Fonds; and EFG Steering 
Committee Member
HIV/AIDS-Related Private 
Philanthropy Represented 6% Of Total 
International Assistance In 2011.6
Global investments in HIV/AIDS in low- and middle-income 
countries totaled $16.8 billion in 2011, up 11% from 2010, with 
international assistance remaining largely flat since 2008.7 The 
largest increase was seen in domestic resources where funding 
grew by more than 15% between 2010 and 2011, and now 
support more than 50% of the global response.8












6 Source: UNAIDS. Together We Will End AIDS. 2012. Available at: www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/20120718_
togetherwewillendaids_en.pdf. 
7 The Henry J. Kaiser Family Foundation. Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European 
Commission and Other Donor Governments in 2011. July 2012. Available at: www.kff.org/hivaids/7347.cfm.
8 UNAIDS. Meeting the Investment Challenge: Tipping the Dependency Balance. July 2012. Available at: www.unaids.org/en/media/unaids/contentassets/documents/
epidemiology/2012/20120718_investmentchallengesupplement_en.pdf.
International Assistance Disbursed to Low- and  
Middle-Income Countries for HIV in 2011
(Source: UNAIDS. Together We Will End AIDS. 2012. )
United States President’s Emergency Plan for AIDS Relief (PEPFAR) 
European governments
Other OECD-DAC governments
Global Fund to Fight AIDS, Tuberculosis and Malaria
Other multilateral agencies
Philanthropics
Brazil, Russian Federation, India, China and South Africa and 
non-OECD DAC governments
Needed to meet targets =  $24 billion
Total available resources in 2011 = $16.8 billion
REMAINING GAP =  $7.2 billion in 2011
UNAIDS reports a gap of $7.2 billion in 2011 to reach  


















STAKEHOLDER OUTLINE STRATEGIES FOR INVESTING IN THE END OF AIDS
UNAIDS: STRATEGIC DIRECTIONS  
Investments in the AIDS response must be based on three tenets:  
1.  Equity 
2.  Evidence  
3.  Efficiency
Supported by four fundamental principles:  
1.  Country ownership 
2.  Community engagement 
3.  Shared responsibility and global solidarity 
4.  Grounded in the local epidemiological context
(Source: UNAIDS. Meeting the Investment Challenge: Tipping the Dependency Balance. July 2012.)
amfAR and AVAC: AREAS OF FOCUS FOR ENDING AIDS 
The following are cost-effective approaches that can best reduce HIV incidence and AIDS-related morbidity and mortality: 
•  HIV testing 
•  HIV treatment  
•  Voluntary medical male circumcision  
•  Prevention of vertical transmission 
•  Focused, evidence-based prevention programs for key populations
(Source: amfAR and AVAC. An Action Agenda to End AIDS: Critical Actions from 2012-2016 to Begin to End the HIV/AIDS Pandemic. July 2012. Available at: 
www.avac.org/ht/a/GetDocumentAction/i/4.)
THE VALUE OF ADVOCACY  
According to the National Committee for Responsive Philanthropy, funding advocacy is an excellent way to leverage limited 
resources. Their recent study showed that advocacy funding consistently provides a high return on investment, with each dollar 
granted by donors reaping an average of $115 in community benefit.
(Source: Lisa Ranghelli, The National Committee for Responsive Philanthropy [NCRP]. Leveraging Limited Dollars: How Grantmakers Achieve Tangible Benefits  
by Funding Policy and Community Engagement. January 2012. Available at: www.ncrp.org/files/publications/LeveragingLimitedDollars.pdf).
ABOUT FCAA AND EFG
Founded in 1987, Funders Concerned About AIDS (FCAA) 
is the only U.S.-based organization comprised of and for, private 
philanthropic institutions concerned about, engaged in, or potentially 
active in, the fight against HIV/AIDS. Our mission is to mobilize the 
leadership, ideas and resources of U.S.-based funders to eradicate 
the HIV/AIDS pandemic – domestically and internationally – and to 
address its social and economic dimensions. FCAA marks its 25th 
year in 2012 by recommitting to its mission in effort to both expand 
and strengthen the philanthropic response to AIDS. FCAA will work 
to expand the pool of philanthropic resources focused on HIV/AIDS 
by working with key partners in health and social justice philanthropy 
to identify points of leverage and opportunities for synergy. FCAA 
will also continue to convene public and private funders – providing 
time, space and resources to build a stronger network of increasingly 
collaborative funders, utilizing a coordinated and data-driven 
investment approach in order to leverage the opportunities presently 
available and to continue to increasingly identify new, efficient, and 
impactful approaches to end the AIDS epidemic.
The European HIV/AIDS Funders Group (EFG), established 
in 2002, is a knowledge-based network dedicated to strengthening 
European philanthropy in the field of HIV/AIDS. The group aims to 
mobilize European philanthropic leadership and resources to address 
the global HIV/AIDS pandemic and its health, social and economic 
consequences. The main objectives of EFG are to identify European 
foundations engaged in HIV/AIDS work; to facilitate the sharing of 
experiences and perspectives among funders, thereby helping them to 
learn from each other’s successes and failures in this complex funding 
area; and to discuss opportunities for better information exchange 
and cooperation. In doing so, it also seeks to promote an enabling 
environment for strategic and independent giving in this field as well 
as fields closely connected to HIV/AIDS such as human rights, global 
health and global development. 
U.S. PHILANTHROPIC SUPPORT












FCAA surveyed funders about funding 
disbursements and commitments in 2011. 
  ›  Tracking disbursements (funding 
actually made available in a given year, 
which may include funding from prior year 
commitments) provides data on funds 
actually paid out in a given year.
  ›  Tracking commitments (funding 
committed for grants/projects in a given 
year, whether or not the funds were 
disbursed in that year) helps to gauge 
current and future outlays.  
 For some funders, commitments and 
disbursements are the same in a given  
year; for others, commitments indicate 
funding above or below actual disbursements 
in a year.
Sixty-nine funders are categorized as 
“top” HIV/AIDS funders because they 
reported HIV/AIDS-related grantmaking 
disbursements of $300,000 or more in 2011. 
About the Top Funders list: The following 
table provides a tool to measure our progress 
in building the field of HIV/AIDS philanthropy 
by offering an indication of how many 
funders focus on HIV/AIDS. The science 
isn’t perfect, however. While a funder may 
fall below $300k due to annual fluctuations 
or restructuring, that doesn’t change their 
commitment to the field, and some of our 
fiercest advocates and champions in the 
sector fund below the $300,000 level. As 
we continue to use this metric to measure 
movement, we also encourage every funder 
to participate in this process. In addition 
to funding by the 69 top funders (see list 
below), the total $491 million in HIV/AIDS 
disbursements also includes the efforts of  
205 other organizations (representing 2%  
of total funding) that provided support to 
HIV/AIDS in 2011. 
9 Funding for HIV/AIDS to the Global Fund to Fight AIDS, Tuberculosis and Malaria from HIV/AIDS philanthropic funders was removed from all figures in the report, because it is 
increasingly difficult to track accurately. Please see page 50 for more information.
10 The state associated with each entity refers to the state in which the entity is based, not necessarily where grants and projects are funded by the entity. 
11 The 2011 totals for the Gates Foundation, M•A•C AIDS Fund and M•A•C Cosmetics, and Open Society Foundations do not include HIV/AIDS funding to the Global Fund. Please 
see page 50 for more information.
12 ViiV Healthcare is a specialist HIV company established in November 2009 by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. 
The company has headquarters in both the United States and the United Kingdom and the grantmaking is global in nature. As such, the 2011 total for ViiV Healthcare appears in 
both the U.S. and European sections of this report. 
U.S. Philanthropic HIV/AIDS Funders in 2011
KEY FINDINGS
Total funding in 2011: HIV/AIDS disbursements from 274 U.S.-based philanthropies totaled $491 million in 2011, supporting some 
5,561 HIV/AIDS-related projects and grants.9 
Table 1. Top 69 U.S. Philanthropic HIV/AIDS Funders in 2011 (ranked by amount of disbursements)10 
Funder name Disbursements ($) Commitments ($)
1. Bill & Melinda Gates Foundation, WA11 238,000,000 552,000,000
2. M•A•C AIDS Fund and M•A•C Cosmetics, NY11 32,876,920 35,708,929
3. Merck, NJ 20,023,968 20,023,968
4. Ford Foundation, NY 18,676,242 16,740,147
5. Abbott and Abbott Fund, IL 17,437,222 17,437,222
6. ViiV Healthcare, NC12 15,079,833 15,079,833
7. Gilead Sciences, Inc., CA 12,199,656 5,679,882
8. Philip T. and Susan M. Ragon Institute Foundation, MA 10,000,000 10,000,000
9. Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Co., NY 9,507,095 6,398,004
10. Broadway Cares/Equity Fights AIDS, NY 9,220,200* 9,220,200


















Table 1. Top 69 U.S. Philanthropic HIV/AIDS Funders in 2011 (continued) 
Funder name Disbursements ($) Commitments ($)
11. Johnson & Johnson, NJ 9,182,534 9,182,534
12. Open Society Foundations, NY11,13 8,476,705 8,476,705
13. AIDS United, DC 7,838,296* 8,943,514
14. Elton John AIDS Foundation, NY 7,506,871 8,316,871
15. Irene Diamond Fund, NY 7,254,602 7,254,602
16. amfAR, The Foundation for AIDS Research, NY 5,463,182* 7,643,041
17. Foundation for the NIH, MD 5,380,944* 48,487,510
18. Robin Hood Foundation, NY 4,181,250 4,181,250
19. Elizabeth Glaser Pediatric AIDS Foundation, CA 3,637,647* 3,567,930
20. American Jewish World Service, NY 2,841,600* 2,841,600
21. Keep a Child Alive, NY 2,550,557 2,550,557
22. The Starr Foundation, NY 2,500,000 2,500,000
23. Levi Strauss & Co., CA 2,400,000 2,972,000
24. Tides Foundation, CA14 2,387,243 2,387,243
25. Pfizer Inc, NY15 2,367,213 2,367,213
26. AIDS Foundation of Chicago, IL 2,017,039* 2,144,369
27. J. E. and L. E. Mabee Foundation, Inc., OK16 2,000,000 2,000,000
28. The New York Community Trust, NY 1,867,000* 1,867,000
29. Global Fund for Women, CA 1,787,850* 1,904,350
30. Firelight Foundation, CA 1,689,600* 2,076,100
31. Washington AIDS Partnership, DC 1,655,755* 1,526,809
32. Conrad N. Hilton Foundation, CA 1,561,000 2,955,000
33. Janssen Therapeutics, NJ17 1,500,000 1,500,000
34. Wells Fargo, CA 1,451,482 1,451,482
35. Doris Duke Charitable Foundation, NY 1,371,000 0
36. Pride Foundation, WA 1,357,308 1,357,308
37. H. van Ameringen Foundation, NY 1,328,000 1,328,000
38. Alphawood Foundation, IL18 1,323,000 1,323,000
39. Kaiser Permanente, CA 1,200,000 545,000
40. Glaser Progress Foundation, WA 1,051,901 1,051,901
41. South Africa Development Fund, MA 1,045,900* 1,045,900
42.  International Treatment Preparedness Coalition (ITPC),  
a project of the Tides Center, CA19 1,020,566* 1,020,566
43. Chevron Corporation, CA 1,005,000 20,000,000
44. James B. Pendleton Charitable Trust, WA 892,646 892,646
45. Macy's Foundation, OH 850,000 850,000
46. Robert Wood Johnson Foundation, NJ 800,000 800,000
47. Staying Alive Foundation, NY20 795,706 801,950
13 The 2011 dollar amounts provided by the Open Society Foundations are estimates and not exact figures. The estimated disbursements only reflect external, HIV/AIDS-related 
cash grants from 1) the Soros Foundation Network’s Public Health Program, 2) the Burma Project, and 3) national and regional foundations. These numbers do not include HIV/AIDS 
funding from any other programs within the Soros Foundations Network, though it is possible, that other programs within the Soros Foundations Network may also have provided 
HIV/AIDS-related funding in 2011. 
14 The Tides Foundation figure does not include grants made by the International Treatment Preparedness Coalition (ITPC), a project of Tides Center that for the purposes of this 
report has been listed separately.
15 This figure includes grants from Pfizer Inc, but should be regarded as an estimate that does not include all HIV/AIDS funding from Pfizer Inc and the Pfizer Foundation due to the 
unavailability of complete data.
16 The sole grant recipient of the J.E. and L.E. Mabee Foundation, Inc. is Legacy Community Health Services, which specializes in HIV testing, education, treatment and social 
services. Legacy Community Health Services also provides no-cost or low-cost healthcare services care for other chronic health conditions, so not all of this grant necessarily goes 
toward HIV-focused work.
17 Janssen Therapeutics is part of the Johnson & Johnson family of companies, but for the purposes of this report has been considered separately.
18 The Alphawood Foundation operates on a fiscal year basis, so calendar year 2011 included grants from two fiscal years (2010 and 2011).
19 ITPC is fiscally managed by Tides Center, and all ITPC grants are therefore legally made from Tides Foundation. For the purposes of this report, however, ITPC and the Tides 
Foundation have reported separately.
20  The Staying Alive Foundation, based in the U.S. and the U.K., operated in the U.K. as a registered charity for the first time in 2011. The U.K. program is similar to that of the U.S., 
but currently at a smaller scale. Both programs are included in this report, with the U.S. program in the FCAA section and the separate U.K. program in the EFG section.












Table 1. Top 69 U.S. Philanthropic HIV/AIDS Funders in 2011 (continued) 
48. The Brown Foundation, Inc., TX21 750,000 850,000
49. The Comer Foundation, IL 710,000 710,000
50. The John D. & Catherine T. MacArthur Foundation, IL 710,000 685,000
51. Weingart Foundation, CA 640,500 640,500
52. The Summit Foundation, DC 634,902 889,902
53. The Health Foundation of Greater Indianapolis, IN 615,410 615,410
54. San Francisco AIDS Foundation, CA 534,000 484,000
55. East Bay Community Foundation, CA21 524,003 524,003
56. San Diego Human Dignity Foundation, CA 505,554 505,554
57. Zonta International Foundation, IL 500,000 500,000
58. Design Industries Foundation Fighting AIDS (DIFFA), NY 496,424 496,424
59. The Campbell Foundation, FL 479,919 479,919
60. Healthcare Foundation of New Jersey, NJ 476,856 476,856
61. Houston Endowment Inc., TX 470,000 695,000
62. Community Foundation for Greater Atlanta, GA 450,000 450,000
63. BD (Becton, Dickinson and Company), NJ 425,572 425,572
64. San Francisco Foundation, CA21 411,807 411,807
65. Walmart Foundation, AR 402,167 402,167
66. Denver Foundation, CO 398,000 398,000
67. Harry and Jeanette Weinberg Foundation, Inc., MD21 396,780 396,780
68. Boston Foundation, MA21 352,472 352,472
69. Arcus Foundation, MI 300,000 300,000
2011 HIV/AIDS Grantmaking Disbursements by Top 6922 $479,244,692
2011 HIV/AIDS Grantmaking Disbursements by funders 70-27423 $11,767,354
2011 HIV/AIDS Grantmaking Commitments by Top 69 $870,091,502
Total 2011 U.S. HIV/AIDS Grantmaking Disbursements24 $491,012,046
(To view previous years’ HIV/AIDS grantmaking totals for individual funders (2005-2010), please visit www.fcaaids.org/resourcetracking)
21 Financial information for the Brown Foundation, the East Bay Community Foundation, the San Francisco Foundation, the Harry and Jeanette Weinberg Foundation, Inc., and the 
Boston Foundation was obtained from an annual report or 990 form, and is for fiscal year 2011 (July 2010 to June 2011) rather than calendar year 2011. 
22 Funders with an asterisk (*) after their total reported that they received some financial resources from other funders tracked by FCAA. Totals for those funders who reported 
receiving re-granting funds include the re-granted funds. To avoid double counting of funds, total disbursements for all grantmakers reflects a reduction of $18,500,207 to correct for 
re-granting of funds from one FCAA-tracked top grantmaker to another. See the methodology online at www.fcaaids.org/resourcetracking for a full explanation.
23 In addition to funding by the 69 top funders, the total $491 million in HIV/AIDS disbursements also includes the efforts of 205 other organizations with total disbursements of less 
than $300,000. 
24 Note on missing data: The majority of private philanthropic funding for HIV/AIDS in 2011 has been captured in the available data. However, it is important to note that despite 
repeated efforts, FCAA was unable to obtain data from some funders. Several other funders that have appeared in previous reports are not included this year for various reasons. 
They include the United Nations Foundation, which increasingly does not exclusively focus on HIV/AIDS and cannot disaggregate HIV/AIDS-specific funding from grants made 
towards reproductive health and other health areas, the Silicon Valley Community Foundation, and the Children Affected By AIDS Foundation, which closed as its own foundation 
in 2012 after joining forces with the organization Keep a Child Alive. Other funders are missing from this list due to yearly fluctuations in funding, or changes in grantmaking focus 
areas and/or amounts to HIV/AIDS.
NEW TOP FUNDERS: In last year’s  
report on 2010 giving, FCAA highlighted  
a troubling trend that the number of top  
HIV/AIDS funders – those giving $300,000  
or more – had decreased by nearly 30% since 
2005. This year’s list of 69 funders features 
five organizations for which FCAA has 2010 
and 2011 data that increased funding from 
their 2010 totals to above $300,000 in 2011: 
The J.E. and L.E. Mabee Foundation, Inc.; the 
Brown Foundation; the Boston Foundation; 
the East Bay Community Foundation; and 
the Healthcare Foundation of New Jersey. 
This growth was offset, however, by five top 
funders from 2010 that are no longer included 
on the top funders list because their funding 
dropped below $300,000. 
FUNDERS NEW TO RESOURCE 
TRACKING REPORTING: Table 1 
includes data from 13 funders in 2011 that 
were not included in the report on 2010 
funding because FCAA was not able to 
obtain their 2010 financial data. These 
funders include: Gilead Sciences, Inc; the 
Foundation for the NIH; Keep a Child Alive; 
Janssen Therapeutics; Kaiser Permanente; 
Chevron Corporation; Macy’s Foundation; 
Zonta International Foundation; the 
Community Foundation for Greater Atlanta; 
the San Francisco Foundation; the Walmart 
Foundation; the Denver Foundation; and  
the Harry and Jeannette Weinberg 
Foundation, Inc. These funders are not new 
to funding the HIV/AIDS response in 2011; 
they likely supported HIV/AIDS in 2010 but 
their 2010 data on HIV/AIDS funding was not 
shared or available.
Funder name Disbursements ($) Commitments ($)


















Year-to-Year Comparison of U.S. Philanthropic HIV/AIDS 
Disbursements and Commitments 
Chart 1b. 2010 – 2011 Changes in Disbursements 
Top funders other  
than Gates Foundation - $11 million
Gates Foundation + $23 million
Funders new to  
the report + $20 million
Total change  
2010 - 2011 = + $32 million
60%




Small increase from 2010-2011 led by three top 10 funders: 
Among U.S.-based funders for which FCAA has two years of 
comparable data (2010 and 2011), disbursements for HIV/AIDS 
increased, but only by 3%, or $11 million ($449 million in 2010 to 
$460 million in 2011). Significant increases in disbursements for 
HIV/AIDS from a few of the top 10 funders in 2011, including the 
Gates Foundation (which represented half of all total U.S.-based 
disbursements), M•A•C AIDS Fund and ViiV Healthcare, were 
largely offset by a disturbing trend of reductions by the majority.
Majority of funders decreased funding to HIV/AIDS from  
2010-2011: Over 60% of top funders saw decreases in funding for 
HIV/AIDS from 2010 to 2011. Funding decreased by 5% (from $234 
million in 2010 to $223 million in 2011) among funders other than 
the Gates Foundation, for which FCAA has two years of data. This 
included decreased funding from three top 10 funders in 2010 that 
indicated that their HIV/AIDS funding would decrease in 2011 due 
to a shift of funds to other related health areas, such as sexual and 
reproductive health and rights, neglected diseases, chronic hunger 
and malnutrition, and maternal and child health.
Chart 1a. Total U.S. HIV/AIDS Philanthropic Disbursements: 2005-2011 
The chart below shows aggregate funding disbursements per year for all funders. Funding to the Global Fund was removed from all totals below 
(see page 50 for more information about funding to the Global Fund).
Gates Foundation All other fundersTotal
Disbursements per year for all funders (in $ millions)




























Chart 1c. Total HIV/AIDS Philanthropic Disbursements by U.S. Funders 2005-2011 (for 48 funders which seven years 
of data are available)
To examine year-to-year trends, the chart below uses a subset of only those funders for which all seven years of data were available (2005-2011), 
48 of 274 funders. Those 48 funders represented 86% of all funding in 2011 (a total of $423 million). 
Gates Foundation All other fundersTotal







Disbursements for 48 funders for which seven years of data is available (in $ millions)
3%higher total value of  disbursements than 2010








Chart 2. Total HIV/AIDS Philanthropic Commitments by U.S. Funders 2000-201125
25 All commitments data available for all funders is included in the chart for each year, including funders’ totals from Foundation Center and Foundation Search data. This is a 
change from the methodology of this chart in previous years’ reports, when some Foundation Center and Foundation Search data was not included. Historical commitment figures 
have also been adjusted to remove funding for HIV/AIDS to the Global Fund to Fight AIDS, Tuberculosis and Malaria. 
Gates Foundation All other fundersTotal
Commitments for all funders for which data was available (in $ millions)























The 215% increase over 2010 in commitments 
by all funders is due in large part to $552 
million in multi-year commitments reported 
by the Bill & Melinda Gates Foundation 
as part of a new strategy and grants cycle 
in 2011. It should be noted that the Gates 
Foundation forecasts disbursements for  
2012 to remain roughly the same. 
Among funders other than the Gates 
Foundation for which both 2010 and 
2011 commitments data are available, 
commitments increased only $7 million  
(or 3%) from 2010 to 2011, from $232  
million to $239 million.
All of the following FCAA charts and 
tables refer to disbursements.


















Concentration of U.S. Philanthropic HIV/AIDS Funders 
KEY FINDINGS
Funding remains highly concentrated among top 10: The top 10 funders accounted for 80% (or $392 million) of all disbursements.  
The Gates Foundation alone accounted for 49%.
Chart 3. Distribution of Disbursements by U.S. Philanthropic HIV/AIDS Funders in 2011 (by percentage of total disbursements)
LARGEST FUNDER: The creation of the Bill & Melinda Gates Foundation in 2000 was a milestone in a new era of growth in 
global AIDS philanthropy. As the largest private funder of HIV/AIDS, the Foundation has committed more than $2.5 billion in HIV 
grants to date, as well as more than $1.4 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria. With a program goal to 
“significantly reduce the incidence of HIV infection and extend the lives of people living with HIV,” the Foundation has prioritized six 
areas, including: vaccine research and development; antiretroviral prevention methods; efficient and effective service delivery (such 
as reducing the costs of ARVs, evaluation of combination prevention methods, and collaborating with other HIV financing partners); 
voluntary medical male circumcision; improved diagnostic methods; and, demonstrating the scalability of HIV programs. 
 “ Innovation is the key to improving the 
world. When innovators work on urgent 
problems and deliver solutions to people  
in need, the results can be magical.”
- Annual Letter 2012 from Bill Gates 
(Available at: www.gatesfoundation.org/annual-letter/2012/Pages/home-en.aspx)
49%





















U.S.-Based Corporate Philanthropic HIV/AIDS Funders 
KEY FINDINGS
A key role in the response: Fifteen corporate foundations and giving programs – including six of the top 10 funders – represented 26% 
(or $127 million) of total U.S. HIV/AIDS philanthropy for 2011, and about half of the total disbursements from funders other than the 
Gates Foundation. Comparatively among general philanthropy, corporate funders represent only 5% (or $14.5 billion) of total charitable 
giving in the U.S.
Table 2. Top U.S.-based Corporate Philanthropic HIV/AIDS Funders in 2011  (ranked by amount of disbursements) 
M•A•C AIDS Fund and M•A•C Cosmetics, NY $32,876,920
Merck, NJ 20,023,968
Abbott and Abbott Fund, IL 17,437,222
ViiV Healthcare, NC 15,079,833
Gilead Sciences, Inc., CA 12,199,656
Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Co., NY 9,507,095
Johnson & Johnson, NJ 9,182,534
Levi Strauss & Co., CA 2,400,000
Pfizer Inc, NY 2,367,213
Janssen Therapeutics, NJ 1,500,000
Wells Fargo, CA 1,451,482
Chevron Corporation, CA 1,005,000
Macy’s Foundation, OH 850,000
BD (Becton, Dickinson and Company), NJ 425,572
Walmart Foundation, AR 402,167
Total $126,708,662
Funder name Amount


















Forecast for U.S. Philanthropic HIV/AIDS Funding
KEY FINDINGS
2012 forecasted to remain the same: Almost half (45%) of funders that shared their anticipated grantmaking for 2012 (49 of 69) 
forecast funding for HIV/AIDS would stay about the same compared to 2011, including the highest funder, the Gates Foundation,  
and four other top 10 funders.
Chart 4. Forecast of 2012 U.S. Philanthropic HIV/AIDS Funding26 (by percentage of funders responding)
45%
Expect funding to  
remain the same in 2011
22%
14%
19%Expect funding to 
decrease in 2011 Unsure
Expect funding to 
increase in 2011
26 It should be noted that only about half of the predictions for 2011 funding from the previous year’s survey on 2010 funding were correct (19 of 37 responses, including five of nine 
top 10 funders). The majority of the remainder of the responses (14 of 37) predicted funding would stay the same or increase in 2011 when it actually decreased.
Includes Gates Foundation 
and four other top 10 funders












Geographic Distribution of U.S. Philanthropic HIV/AIDS Funding 
KEY FINDINGS
Majority of funding was directed to projects with a global aim: Projects that target a worldwide population (such as research) 
received the highest amount of funding in 2011, representing 44% (or $221 million) of all disbursements. This was followed by funding 
to specific countries and regions outside of the U.S., which accounted for 36% ($179 million), while about 20% (or $98 million) was 
directed toward the domestic U.S. epidemic. 
Chart 5a. Share of Total U.S. Philanthropic HIV/AIDS 
Disbursements in 2011 by Geographic Focus (by percentage 
of total expenditure, for 68 of 69 top funders)
Chart 5b. Geographic Focus for Funders Other than 
Gates Foundation (by percentage of total expenditure)
36%







For projects of 
global benefit
NEW FOR 2012: In response to feedback, FCAA and EFG added the new geographic category “Projects 
with a Global Aim” to capture funding with more of a worldwide reach or target population than 
a national or regional impact. Other international funding disbursed to specific countries or regions 
outside of the U.S. is captured in the “National and Regional-level Projects Outside the U.S.” section.
38%







For projects of 
global benefit


















Although the lowest percentage of 
expenditure went to the domestic epidemic, 
the largest percentage (37%, or 25 of 68 
funders) of funders indicated they  
provided funding exclusively to address  
the epidemic domestically.   
Chart 6. Geographic Focus of U.S. Philanthropic HIV/AIDS Funders in 2011  
(by percentage of funders responding to question)
28%





Mix of U.S. domestic funding 
and funding outside the 
U.S./global funding












Focus on Domestic U.S. Philanthropic HIV/AIDS Funding 
FCAA identified a total of 49 top funders that 
disbursed funds to address the U.S. domestic 
epidemic. Twenty-one of those funders 
disbursed $1 million or more to support 
domestic U.S. HIV/AIDS programming  
in 2011.  
Table 3. Top U.S. Philanthropic Funders (>$1 Million) of Domestic U.S. HIV/AIDS Work in 2011 
(ranked by amount of domestic disbursements) 
Funder name Domestic ($) % of total HIV/AIDS  disbursements by funder
M•A•C AIDS Fund and M•A•C Cosmetics, NY 13,084,698 40
Gilead Sciences, Inc., CA 8,769,156 72
Broadway Cares/Equity Fights AIDS, NY 8,762,323 95
AIDS United, DC 7,838,296 100
Merck, NJ 5,833,512 29
Ford Foundation, NY 5,273,115 28
Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Co., NY 5,131,916 54
Elton John AIDS Foundation, NY 5,086,871 68
Robin Hood Foundation, NY 4,181,250 100
ViiV Healthcare, NC 2,756,500 18
Abbott and Abbott Fund, IL 2,111,662 12
Johnson & Johnson, NJ 2,087,086 23
J. E. and L. E. Mabee Foundation, Inc., OK 2,000,000 100
AIDS Foundation of Chicago, IL 1,966,539 97
The New York Community Trust, NY 1,867,000 100
Washington AIDS Partnership, DC 1,655,755 100
Janssen Therapeutics, NJ 1,500,000 100
Wells Fargo, CA 1,451,482 100
Pride Foundation, WA 1,357,808 100
H. van Ameringen Foundation, NY 1,328,000 100
Kaiser Permanente, CA 1,200,000 100


















Chart 7 shows the U.S. regional distribution 
of domestic HIV/AIDS philanthropic funding. 
FCAA asks funders to report domestic 
funding according to where the office of  
the grantee is located. It is important to  
note that some funders’ grantees conduct 
HIV/AIDS work outside of the region in 
which they are based. Therefore, the share 
of funding given to a domestic region 
specified in Chart 7 is only an estimate of 
the actual funding spent in the region. New 
this year is the “nationwide” category that 
represents funding for the U.S. that cannot 
be disaggregated to a regional or other sub-
geographic level. 
Chart 7. Regional Distribution of Domestic U.S. Philanthropic HIV/AIDS Funding in 2011  















Total Disbursements by Region  








Domestic U.S. Regional Distribution
KEY FINDINGS
The Northeast and the South both received about $28 million in 2011, and were the U.S. domestic regions that received the highest 
share of funding. 












Table 4. Top U.S. Philanthropic Funders (>$1 Million) of Domestic U.S. HIV/AIDS Work by U.S. Region in 2011 
(ranked by amount of disbursements to grantees based in each region)
NORTHEAST
Broadway Cares/Equity Fights AIDS, NY $6,171,625
M•A•C AIDS Fund and M•A•C  
Cosmetics, NY 5,365,623
Robin Hood Foundation, NY 4,181,250
Gilead Sciences, Inc., CA 2,639,795
The New York Community Trust, NY 1,867,000
SOUTH
M•A•C AIDS Fund and M•A•C Cosmetics, NY $4,101,288
Bristol-Myers Squibb Foundation and  
Bristol-Myers Squibb Co., NY
3,493,685
AIDS United, DC 3,204,403
Gilead Sciences, Inc., CA 2,708,013
Ford Foundation, NY 2,655,000
MIDWEST
AIDS Foundation of Chicago, IL $1,941,539
AIDS United, DC 1,068,509
WEST
Merck, NJ $3,375,350
M•A•C AIDS Fund and M•A•C  
Cosmetics, NY
2,019,311
AIDS United, DC 1,662,406
Gilead Sciences, Inc., CA 1,387,837
Kaiser Permanente, CA 1,152,000
The U.S. South consistently has the highest rate of new HIV infections and the highest number of people living with HIV/AIDS of 
all U.S. regions, as well as the highest number of AIDS diagnoses and AIDS deaths. A report from the Southern HIV/AIDS Strategy 
Initiative suggested that some factors that may be contributing to the impact of HIV in the South include general health status (U.S. 
South ranks low overall on health), poverty, race/ethnicity and gender issues, stigma, and laws and policies that fail to prevent HIV 
transmission, such as abstinence-based sexual education and criminalization of needle-syringe programs.25










Source: Centers for Disease Control and Prevention. HIV Surveillance 
Report, Vol. 22. 2012. Available at: www.cdc.gov/hiv/surveillance/
resources/reports/2010report/index.htm
Note: Chart includes both estimated adults and adolescents living with 
diagnosis of HIV infection and AIDS diagnosis in the Unites States.
Source: Centers for Disease Control and Prevention. HIV Surveillance  











Estimated New HIV Infections in the U.S. 
in 2010 by Region
Estimated People Living with HIV in the 
U.S. by Region (up to end of 2009)


















25  Southern HIV/AIDS Strategy Initiative. HIV/AIDS Epidemic in the South Reaches Crisis Proportions in Last Decade. Duke Center for Health Policy and Inequalities Research 
(CHPIR), Duke University, Durham, NC. December 2011. Available at: http://globalhealth.duke.edu/news/2011/ResearchReportFinal3-12.pdf.
 ›  The Ford Foundation supported a number of initiatives 
in 2011 to address HIV/AIDS in the U.S. South, including: 
grant resources and technical support for AIDS United’s 
Southern REACH (Regional Expansion of Access and 
Capacity to Address HIV/AIDS) Initiative to broaden 
and strengthen community infrastructure; support to 
Duke University for the AIDS Legal Project to develop 
policy and strategy recommendations around the 
implementation of the U.S. National HIV/AIDS Strategy 
in the Southeastern U.S.; and support to Human Rights 
Watch to examine the disproportionate impact of HIV 
among marginalized communities in the southern U.S. 
 ›  In 2011 the New York City AIDS Fund in the New York 
Community Trust prioritized the simultaneous funding  
of policy, treatment and organizational management 
to help control the spread of HIV in New York City. 
Examples of this strategy included support to: the Ali 
Forney Center to build an integrated electronic database 
to better coordinate services for homeless LGBT youth 
at-risk for HIV infection; the organization Gay Men of 
African Descent for a peer-led HIV prevention program 
for young black and Latino men who have sex with men; 
HELP/PSI to open a primary care center as part of a 
syringe-exchange program; the Correctional Association 
of New York to monitor and improve healthcare for  
HIV-positive inmates in New York state prisons; and the 
Asian & Pacific Islander Coalition on HIV/AIDS to help 
prepare AIDS service organizations to become federally 
qualified health centers. 
 ›  In 2011 AIDS United dedicated significant staff time and 
resources to create an independent grantmaking pool 
for Puerto Rico. The direct grants portfolio of $250,000 
(funded by Johnson & Johnson, Merck, M•A•C AIDS 
Fund, the H. van Ameringen Foundation, and the Elton 
John AIDS Foundation) has supported syringe exchange, 
programs for men who have sex with men, and programs 
for women and girls across Puerto Rico. AIDS United  
has also convened community and philanthropic leaders 
to both help develop and support this new focus on 





Puerto Rico CoNCRA – Peer Educator for the HSH 
(MSM in English) outreach program. 












The “other” category for domestic intended 
use includes funding that was unspecified 
and funding for projects that did not fall 
under the pre-determined categories, such 
as: health system strengthening; work 
against stigma; management, leadership 
and other organizational capacity building; 
assistance in streamlining business 
functions; technical assistance to HIV/AIDS 
service providers; and support of hospice 
care. The research category here  
is significantly lower than 2010 as a 
significant portion of that work is now 
reflected in the “projects with a global  
aim” section on page 46. 
Intended Use of U.S. Philanthropic HIV/AIDS Funding for the Domestic U.S. Epidemic
KEY FINDINGS
Prevention projects received the biggest share of U.S. domestic funding ($23 million), followed by treatment ($21 million), and social 
services ($21 million). 
Chart 8. Intended Use of U.S. Philanthropic HIV/AIDS Funding for the Domestic U.S. in 2011 (for 48 of 49 top funders)







































 ›  Gilead’s HIV FOCUS program (HIV on the Frontlines 
Of Communities in the United States) partners with 
healthcare providers, government agencies and 
community organizations to: make routine HIV screening 
a standard of care; reduce the number of undiagnosed 
individuals, and ensure strong linkages to care; expand 
stakeholder dialogue on HIV and overcome HIV-related 
stigma that may discourage testing. HIV FOCUS works 
with partners in 10 cities that represent 45% of people 
living with HIV/AIDS in the U.S., including: Atlanta, 
Baltimore, Houston, Chicago, Los Angeles, Miami, New 
Orleans, New York, Philadelphia, and Washington, D.C. In 
one partnership with the Department of Motor Vehicles 
(DMV) in D.C., free HIV testing is offered for customers 
while they wait for their driving licenses – a first-of-its-kind 
initiative. In another, Urban Health Plan (UHP), a network 
of Federally Qualified Health Centers in the South 
Bronx and Corona Queens, New York, instituted routine 
screening through integrated processes and use of the 
electronic health record to measure offer and acceptance 
rates. HIV testing increased from just 8% to 50% in the 
first year of implementation. UHP is now planning to 
disseminate this best practice to several other health 
centers in New York City.
 ›  The AIDS Foundation of Chicago has launched several 
access to HIV care initiatives in light of developments in 
treatment as prevention (TasP). Connect2Care (C2C), 
which is largely funded by the AIDS United Social 
Innovation Fund grant, is focused on transforming 
Chicago’s HIV/AIDS sector by more closely linking 
healthcare providers with community-based organizations 
that provide critical supportive services that help people 
living with HIV/AIDS stay healthy and engaged in care. 
Another citywide initiative – Project Identify, Navigate, 
Connect, Access, Retain, and Evaluate (IN-CARE) – uses 
a multi-agency, multifaceted intervention model aimed at 
facilitating access to and retention in HIV healthcare for 
men in Chicago. The project also features an assessment 
tool to help identify key barriers that prevent men of 
color living with HIV/AIDS from accessing or staying in 
care. For more on TasP, please see page 52.
Prevention
The Urban Health Plan
A young man is tested for HIV on Chicago’s South Side through a 
testing initiative coordinated by the AIDS Foundation of Chicago that 
links newly-diagnosed people to care. (AFC Photo-Ed Negron)
Treatment
FUNDING EXAMPLES












 ›  The Weingart Foundation supports the Shanti  
Orange County’s Shanti Ambassadors program to  
train individuals with HIV to be speakers and 
advocates on behalf of the HIV/AIDS community. 
Shanti Ambassadors are a group of trained volunteers 
that provide advocacy presentations throughout 
Orange County to raise awareness of HIV, encourage 
individuals at-risk to seek testing and treatment, and to 
inform elected officials of the needs of the HIV/AIDS 
community. Program volunteers also assist in guiding 
community leaders in effective policymaking, and 
help to represent the organization in Orange County 
legislative advocacy efforts.
 ›  Broadway Cares/Equity Fights AIDS (BC/EFA) 
supports Safe Haven, an organization based in 
Thomasville, Georgia that has been reaching out to 
people living with HIV/AIDS in 24 rural southwest 
Georgia counties for more than 15 years, supplying 
such necessary primary provisions as nutritious meals, 
personal care items, clothing, linens and appliances. 
Long distances separate clients from their clinic 
appointments and supportive services and, coupled 
with growing gas prices and travel expenses, these 
distances can seem insurmountable. A grant of $7,500 
from BC/EFA to cover transportation and gas expenses 
allows Safe Haven to offer continuous care to those in 
need regardless of their distance.  A new computer-
training program will help to bridge the distances even 
more, keeping clients connected on a daily basis to 
share information and support.
Advocacy
Social Services
New for the 2011 survey, FCAA asked respondents to share examples of domestic-focused work that is aligned 
with, or supportive of, the NHAS. Seven top funders have implemented new guidelines that track and/or 
prioritize grantee relationships to the NHAS. At least 10 funders shared new program priorities that focus on 
routine HIV testing and early treatment initiation that support the Strategy’s goals to help reduce new HIV 
infections. One funder also shared an effort to bridge local treatment gaps by purchasing medications for 
HIV-positive clients that fell through cracks in the AIDS Drug Assistance Program. A number of funders also 
highlighted participation in AIDS United’s multi-million, multi-sponsored Access to Care Initiative (A2C) that 
funds networks of care across the U.S. designed to engage people living with HIV/AIDS in resource-constrained 
settings into support services and link them to care.  
For more information, find eight recommended actions for funders to help advance the goals of the NHAS, as 
well as correlating funders and stakeholder actions in the FCAA toolkit: Funders’ Guide to the National HIV/AIDS 
Strategy www.fcaaids.org/NHASToolkit.
Funders’ and the U.S. National HIV/AIDS Strategy (NHAS)


















The Treatment Cascade 
Of 1.1 million Americans living with HIV, only 25% are virally suppressed.
Percent of all People with HIV











Source: Centers for Disease Control and Prevention. CDC Fact Sheet: HIV in the United States: The Stages of Care. July 2012. Available at: 
www.cdc.gov/nchhstp/Newsroom/docs/2012/Stages-of-CareFactSheet-508.pdf.
Though the numbers of HIV-infected people in the U.S. that are aware of their HIV status have improved over the past decade, with 
an estimated 82% aware of their status in 2009, only about a quarter of all people living with HIV in the U.S. receive the continuous 
care and treatment needed to be healthy and reduce their HIV transmission to others.
Though the Obama Administration was able to complete a process begun by President George W. Bush to lift the decades-long ban 
on federal funding for needle and syringe programs in 2009, Congress reinstated the ban in 2011. Where availability of clean 
needles and other harm reduction activities have been implemented, HIV and hepatitis C transmission have been reduced. As of 
August 2012, the North American Syringe Exchange Network (NASEN, www.nasen.org) counted 203 needle and syringe programs 
operating in 32 states. Given the absence of any federal support, these programs rely on funding from state and local governments 
and philanthropic sources.
FINDING THE GAPS: LINKAGES TO CARE
FINDING THE GAPS: HARM REDUCTION












Top funders were asked to identify the three 
population groups that receive the greatest 
benefit from their domestic funding. The 
categories are not mutually exclusive. (Note: 
Although funders were asked to list only the 
top three target populations of their funding, 
some reported more than three populations. 
In those cases, all populations reported were 
included in Chart 9.) 
New this year, the “People living with  
HIV/AIDS” category was removed from the 
target populations questions in the survey in 
an effort to capture better detail on funding 
to subpopulations of people living with  
HIV/AIDS. Many organizations fund people 
living with HIV/AIDS in a general sense, 
however, and wrote in that response, so  
the category still appears in the target 
population charts.
Funders who supported U.S. medical 
research for HIV/AIDS for domestic benefit 
reported the research targeting youth, people 
who inject drugs, all populations on HIV 
treatment, and uninfected persons.
The “other” category for domestic target 
populations included responses that fell 
outside of the pre-determined categories. 
Funders reported examples as “other”  
such as HIV/AIDS education, all populations, 
no target population, immigrants and  
LGBT communities. 
KEY FINDINGS
African Americans, men who have sex with men, women, and homeless/impoverished persons were the top target populations  
of U.S. domestic HIV/AIDS funding.  
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Chart 9a. Target Populations of U.S. Philanthropic HIV/AIDS Funding for the Domestic U.S. Epidemic in 2011  
(All Top Funders)  (by percentage of 47 top domestic funders from which target populations data were obtained)
Percentage of all top U.S. domestic HIV/AIDS funders
Target Populations of HIV/AIDS Funding for the Domestic U.S. Epidemic 


















0% 20% 40% 60%
Men who have sex with men
African Americans
70% 80%10% 30% 50% 90%
People who inject drugs
Health care workers
Women















Chart 9b. Top 10 Funders
Percentage of top 10 U.S. domestic HIV/AIDS funders
TOP 10: Giving from the top 10 U.S. domestic HIV/AIDS funders represented 67% of philanthropy for 
the U.S. domestic epidemic from top funders in 2011.












 ›  To address severe and persistent disparities in treatment 
outcomes and to help strengthen Black Americans’ link to 
care, Merck has partnered with the Black AIDS Institute 
(BAI) to help expand the Black Treatment Advocates 
Network (BTAN).  The program is designed to train and 
mobilize a team of treatment advocates with a mission 
of linking Black Americans with HIV into care and 
treatment, strengthening local and national leadership, 
and advocating for policy change and research priorities. 
In 2011 the BTAN trained more than 100 new advocates. 
 ›  The M•A•C AIDS Fund (MAF) supported Emory 
University to develop a new intervention for MSM 
couples in the United States. Testing Together represents 
the first attempt to utilize Couples Voluntary HIV 
Counseling and Testing (CVCT) for MSM in the U.S., 
an intervention proven effective at reducing HIV 
transmission with heterosexual couples in Africa. Testing 
Together has conducted an initial rollout of CVCT in 
several U.S. cities with the primary goals of increasing 
the number of counselors trained in MSM CVCT, and 
increasing testing of MSM couples at community based 
organizations. The project will examine uptake of CVCT 
among U.S. MSM through an in-depth evaluation using 
process and satisfaction measures. MAF grant funds 
will support the development of high-quality training 
materials for HIV counselors, as well as “apps” for 
common mobile technology platforms to help guide 
counselors through CVCT procedures and return of HIV 
results. The initial rollout and development of the service 
website were also supported by MAF with contribution 
from Emory’s Center for AIDS Research. 
 ›  The Pride Foundation supported the BABES Network in 
Seattle, a program of the YWCA of Seattle that provides 
peer-based support by and for women living with HIV. 
The BABES Network aims to reduce isolation and 
promote empowerment of women living with HIV, through 
advocacy activities, peer counseling and support groups, 
educational forums and other events. One project works 
to help HIV-positive women and men share their stories 
with local community groups in an effort to reduce stigma 
and increase HIV awareness.
 ›  Since 2005 the Elton John AIDS Foundation (EJAF) 
has invested more than $3.2 million nationally in needle 
exchange and harm reduction services through the 
Syringe Access Fund, a grantmaking partnership with 
AIDS United, the Irene Diamond Fund, Open Society 
Foundations, and the Levi Strauss Foundation, as well 
as another $400,000 in syringe access research and 
advocacy initiatives. In 2011, EJAF made a two-year 
commitment of $1.6 million in grants selected through 
the Syringe Access Fund, and funded approximately 
50 organizations, including: The Lower East Side Harm 
Reduction Center in New York City, The Chicago 
Recovery Alliance, The AIDS Task Force of Greater 
Cleveland, Women with a Vision in New Orleans, Helping 
Individual Prostitutes Survive (HIPS) in Washington D.C., 
and Clean Needles Now in Los Angeles, among others. 
These small, community-based organizations reach more 
than 30,000 people at high risk for HIV infection and 
transmission, distributing more than 10 million syringes, 
and ensuring that patrons receive the health information 
and services they need. 
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Black Americans represented an estimated 13% of the U.S. population in 2011, yet they have the highest rate of new HIV 
infection and new AIDS diagnoses of any race/ethnicity, accounting for an estimated 45% of new HIV infections in 2010. 
Men who have sex with men represented an estimated 2% of the U.S. population in 2009, yet HIV transmission by  
male-to-male sexual contact accounted for 61% of new HIV infections in 2010.
FINDING THE GAPS: BLACK AMERICANS AND MEN WHO HAVE 
SEX WITH MEN
Estimated New HIV Infections in the U.S. by 
Transmission Category in 2010
Source: Centers for Disease Control and Prevention. HIV Surveillance 
Report, Vol. 22. 2012; and United States Census Bureau. State & Country 
Quick Facts: USA. Available at: http://quickfacts.census.gov/qfd/
states/00000.html
(Sources: HIV Prevention Trials Network (HPTN). Press release: New Study Finds Greatly Elevated HIV Infection Rates Among Young Black Gay and Bisexual 
Men in the U.S. July 23, 2012. Available at: www.hptn.org/web%20documents/HPTN061/Results/HPTN061ResultsPR23Jul2012.pdf; and Fact Sheet: HPTN 
061. Available at: www.hptn.org/web%20documents/HPTN061/FactSheet_061_July%202012v2.pdf
AIDS 2012 Web Cast Transcript. Health Disparities and the U.S. MSM HIV Epidemic. July 23, 2012. Transcript provided by the Henry J. Kaiser Family 
Foundation. Available at: http://globalhealth.kff.org/~/media/Files/AIDS%202012/072312MOAC01_disparities_transcript.pdf)
Sources: Centers for Disease Control and Prevention. HIV 
Surveillance Report, Vol. 22. 2012.; and Centers for Disease Control 
and Prevention. Fact Sheet: Estimates of New HIV Infections in the 































The HPTN 061 study conducted by the HIV Prevention Trials Network (HPTN) enrolled over 1500 black men who have sex with men 
between July 2009 and December 2011 to understand the factors and strategies that may affect HIV risk in this population. Participants 
were offered HIV/STI testing and counseling, the help of a peer community navigator to access clinical and social services, and if HIV-
positive, linkages to treatment and care. Some preliminary findings include:
  ›  Though black MSM make up less than half of one percent of the U.S. population, the HIV infection rate among black MSM in the 
study was nearly 50% higher than among white MSM in the U.S.
  ›  Young black MSM (age 30 or younger) are particularly vulnerable to HIV, with an HIV infection rate of 5.9% per year.
  ›  In attempting to understand the discrepancy between black and white MSM HIV infection rates, researchers suggested low rates 
of HIV testing may be one factor. Almost 90% of the men in the study believed they were uninfected or did not know their HIV 
status, and 12% were found to be HIV-positive when tested at the beginning of the study.
  ›  Risky sexual behavior is not a factor, as black gay and bisexual men are not more likely than their white counterparts to 
engage in risky sexual behaviors.
What HPTN 061 Reveals About Black MSM
Estimated New HIV Infections in the U.S. by 
Race/Ethnicity in 2010












Focus on National and Regional Philanthropic 
HIV/AIDS Funding Outside the U.S.
FCAA identified 23 funders out of the top 
69 funders that disbursed $1 million or more 
to support national and regional-level AIDS 
programming outside of the U.S. in 2011.  
In previous years’ surveys, funders reported 
geographical distribution of their funding 
based on the main office location of the 
grant recipient–either ‘domestic’ grantees 
within the United States or ‘international’ 
grantees outside the United States. This year, 
however, an effort was made to distinguish 
funding with a global aim from funding 
directed to specific regions or countries 
outside the U.S. among the international 
grantees. This section explores funding from 
U.S. organizations directed to projects of 
benefit to regions or countries outside of the 
United States. (See page 45 for information 
about funding with a global aim.) 
Table 5:  Top U.S. Philanthropic Funders (>$1 Million) of National and Regional HIV/AIDS Work 
Outside of the U.S. in 2011 (ranked by amount of international disbursements)
Funder name National and regional  projects outside the U.S. ($)
% of total HIV/AIDS  
disbursements by funder
Bill & Melinda Gates Foundation, WA 66,000,000 28
M•A•C AIDS Fund and M•A•C Cosmetics, NY 19,394,722 59
Abbott and Abbott Fund, IL 15,325,560 88
Merck, NJ 14,190,456 71
ViiV Healthcare, NC 10,067,670 67
Ford Foundation, NY 9,048,031 48
Johnson & Johnson, NJ 7,095,448 77
Elizabeth Glaser Pediatric AIDS Foundation, CA 3,637,647 100
Gilead Sciences, Inc., CA 3,230,000 26
Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Co., NY 3,175,179 33
American Jewish World Service, NY 2,658,641 94
Open Society Foundations, NY 2,569,656 30
Keep a Child Alive, NY 2,550,557 100
Elton John AIDS Foundation, NY 2,420,249 32
amfAR, The Foundation for AIDS Research, NY 2,132,207 39
Global Fund for Women, CA 1,787,850 100
Firelight Foundation, CA 1,674,600 99
Conrad N. Hilton Foundation, CA 1,561,000 100
Tides Foundation, CA 1,460,726 61
Levi Strauss & Co., CA 1,360,000 57
Glaser Progress Foundation, WA 1,051,901 100
South Africa Development Fund, MA 1,045,900 100
International Treatment Preparedness Coalition (ITPC),  
a project of the Tides Center, CA
1,020,566 100


















Chart 10. Regional Geographic Distribution of U.S. Philanthropic HIV/AIDS Funding Outside  
of the U.S. in 2011 (by percentage of total international disbursements)
* Funding for grantees with main offices in the United States that are known to use the grant money for national and regional work outside the U.S. are 
counted in the ‘U.S. for international’ figure. This is in contrast to the other categories where funding is granted directly to offices in each region.
Region Total disbursements ($)
East & Southern Africa 69,410,271
South Asia & Pacific 39,699,880
East Asia & Southeast Asia 21,810,008
U.S. for international* 14,497,545
Western & Central Europe 6,825,654
West & Central Africa 5,846,550
Latin America 5,075,753
Eastern Europe & Central Asia 4,625,161
Canada 3,529,267
Caribbean 3,334,411
North Africa & Middle East 2,519,375
Unspecified 1,360,532
39%





East Asia &  






3% Eastern Europe & Central Asia
3% West & Central Africa
North Africa & Middle East1%
Distribution of Funding to Specific Regions Outside the U.S. 
KEY FINDINGS
East and Southern Africa received the most funding of all regions outside of the U.S. ($69 million), followed by South Asia & the 
Pacific ($40 million), and East Asia & Southeast Asia ($22 million). 
Of the top 69 funders in 2011, FCAA 
identified a total of 35 that disbursed funds to 
specific countries or regions to address the 
epidemic outside of the United States. 
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The following chart, sourced from UNAIDS data, shows what each geographic region needs annually to meet the global targets set 
for 2015. Nearly $13 billion is needed in the Sub-Saharan Africa region, followed by $3.8 billion needed in South and Southeast Asia, 
and $2.6 billion needed in the Caribbean and Latin America.
FINDING THE GAPS: RESOURCE NEEDS BY GEOGRAPHIC AREA
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Total: U.S. $24 Billion
Source: UNAIDS. Meeting the Investment Challenge: Tipping the Dependency Balance. July 2012.
East Asia and Oceania
Eastern Europe and Central Asia
Middle East and North Africa
South and South-East Asia


















 ›  The International Treatment Preparedness Coalition 
and amfAR’s GMT Initiative (Gay men, other Men 
who have sex with men, and Transgender individuals 
Initiative, formerly called the MSM Initiative) supported 
the Trinidad & Tobago-based MSM No Political Agenda 
(MSMNPA) in 2011. Billed as “Your #1 choice in the fight 
against AIDS for MSM and gay communities in the 
Caribbean,” the MSMNPA’s print and online newsletters, 
including the FRee FORUM Project, seek to fill the 
information gap that is faced by communities of men who 
have sex with men and people living with HIV/AIDS in  
the region. MSMNPA advances treatment preparedness 
and universal access; care and support services; 
prevention with community-specific information on 
health and behavior; and human rights advocacy to 
address social issues such as stigma and discrimination, 
empowerment, self-esteem.
 ›  Since 2007, the Abbott Fund has invested $4 million 
and Abbott has donated diabetes products and HIV 
tests worth $1.5 million to support AMPATH (Academic 
Model Providing Access to Healthcare), headquartered 
in Eldoret, Kenya. The primary focus of their support 
has been AMPATH’s home-based counseling and testing 
initiative, designed to reach people most impacted by 
the targeted diseases. The use of simple technology 
brings healthcare directly to people’s homes rather than 
requiring them to go to a hospital or clinic, which is often 
a hardship for those without reliable transportation. 
AMPATH’s community 
health workers locate and 
keep track of people in 
remote locations by using 
handheld GPS systems, 
providing rapid HIV tests, 
and entering data into 
smartphones. To date nearly 
700,000 people have been 
tested for HIV and  
other diseases. 
 ›  The Levi Strauss Foundation (LSF) funded partnerships 
with organizations including the Andrey Rylkov 
Foundation, International Treatment Preparedness 
Coalition, the European AIDS Treatment Group, and the 
International HIV/AIDS Alliance in Ukraine for legal and 
media advocacy and grassroots organizing. LSF grants 
also supported capacity building and outreach to ensure 
meaningful engagement by key affected populations 
in efforts to reform harm reduction, HIV/AIDS, and 
tuberculosis treatment policies to meet international 
human rights standards. As a result of partners’ advocacy, 
an amended HIV/AIDS law was passed in Ukraine 
allowing: rapid HIV testing to be performed by non-
governmental entities including NGOs; youth over the 
age of 14 years to access voluntary HIV counseling and 
testing without parental consent; and guaranteed access 
to syringe exchange services and appropriate disposal  
of used needles and syringes. In Russia, advocacy resulted 
in an increase in traditional and online media articles 
about Russian drug policies and the nation’s growing  
HIV/AIDS epidemic.
 ›  Through the Avahan Initiative in partnership with the 
Indian Government, the Bill & Melinda Gates Foundation 
supported Voluntary Health Services, Chennai to 
implement prevention services for female and male sex 
workers and transgenders in the 12 districts of Tamil 
Nadu. The program, the Tamil Nadu AIDS Initiative (TAI), 
aims to reduce risk and vulnerability to HIV infection by 
providing treatment for sexually transmitted infections, 
condom distribution, and programs to create supportive 
social structures for those populations at high risk of HIV. 
The program also has a strong monitoring and evaluation 
component that tracks impact and outcomes to improve 
program performance.  
Caribbean
East and Southern Africa
Eastern Europe and Central Asia
India
FUNDING EXAMPLES
An AMPATH program of a coun-
selor going out into the field to 
conduct HIV testing at home.












FCAA was able to obtain data on intended 
use of international HIV/AIDS grants for all 
35 of the 35 top U.S. HIV/AIDS funders of 
national and regional projects outside of  
the U.S. in 2011. 
The “other” category for intended use of 
national and regional funding outside of the 
U.S. includes funding that was unspecified 
and funding for projects that did not fall 
under the pre-determined categories, such 
as: maternal and child health; health systems 
strengthening; management, leadership 
and other organizational capacity-building; 
integration of sexual and reproductive health 
and HIV services; technical assistance; 
fundraising activities; palliative care; and 
conference support.
KEY FINDINGS
Prevention projects received the biggest share of HIV/AIDS funding ($53 million), followed by treatment ($30 million), and research 
($28 million). 
Chart 11. Intended Use of U.S. Philanthropic HIV/AIDS Funding for National and Regional Work Outside of the U.S. in 2011
Disbursements (in $ millions) for all funders




















Intended Use of Philanthropic HIV/AIDS Funding for National and Regional Projects 
Outside of the U.S. 
The following chart, sourced from 
UNAIDS data, shows the estimated 
resource needs for the year 2015 
by category, based on the key 
components of the Investment 
Framework (see page 53 for more 
information about philanthropic 
funders and the Investment 
Framework), to meet the global 
targets set for 2015.
FINDING THE GAPS: 
RESOURCE NEEDS BY 
CATEGORY
Estimated Resource Needs in Low- and Middle-Income Countries for 











Total: U.S. $22 Billion
Source: Schwartländer B, et al. “Towards an improved investment approach for an effective response to HIV/AIDS.” The Lancet. Volume 377, Issue 9782, 
Pages 2031 – 2041. 11 June 2011. Available at: www.ncbi.nlm.nih.gov/pubmed/21641026
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 ›  Johnson & Johnson supports the Partnership for 
Management Development (PMD), a program designed 
to accelerate the elimination of vertical transmission 
of HIV from mother to child (EMTCT) by developing 
leadership skills and management capacity, as well as 
by training host country governments in management 
and leadership. Program participants are Ministry of 
Health officials at national and district levels, as well as 
implementing partners responsible for service delivery 
to achieve elimination of vertical transmission. These 
participants are trained in: financial management, 
leadership, human resources and change management, 
organizational planning, operations management, 
data-based management, supply chain management, 
and social marketing. These skills will also be useful for 
countries considering implementation of a B+ model for 
EMTCT. The PMD has been implemented in Lesotho 
and Swaziland, and an upcoming PMD is planned for 
South Africa.
 ›  Bristol-Myers Squibb Foundation worked with 
Baylor International Pediatric AIDS Initiative (BIPAI), 
governments in sub-Saharan Africa, and other funders 
to help ensure that children received needed treatment 
and care in six hard-hit countries in sub-Saharan Africa 
(Botswana, Lesotho, Swaziland, Malawi, Tanzania, and 
Uganda). The partnership led to the creation of seven 
Children’s Clinical Centers for Excellence and the 
Pediatric AIDS Corps of physicians. A key element of the 
partnership also included developing partnerships with 
local ministries of health. Originally the BMS Foundation 
excluded project funding specifically for clinics and 
physicians; however, through local consultation they 
soon came to see that not only are these essential 
components not sustainable on government funding 
alone, but they also serve as important catalysts to 
encourage additional funding partners. As of June 2011, 
103,731 children had been enrolled into care. Another key 
funder of the initiative, Abbott and the Abbott Fund, has 
helped pioneer innovative model programs to combat 
the disease, including building the BIPAI’s first pediatric 
outpatient clinic in Romania in 2001, which has served an 
average of 700 patients per year. The clinic has reduced 
pediatric HIV mortality rates by more than 90%. Today 
Baylor has replicated the Romania model in additional 
clinics throughout Africa and now serves more than 
100,000 children and young people with HIV – including 
those at two clinics built by and supported by the Abbott 
Fund in Malawi and Tanzania. To date, Abbott and the 
Abbott Fund have contributed more than $50 million in 
products and grants to BIPAI.
 ›  Open Society Foundations supports Light of Hope, an 
NGO that provides health services to people who use 
drugs or are living with HIV in Ukraine, where 40% of 
new HIV infections in 2009 were due to unsafe drug use. 
The country is also home to one of the largest Hepatitis 
C (HCV) epidemics, yet there is little to no access to 
treatment due to drug costs, unavailable diagnostics, 
and a general lack of public awareness. In 2011 Light of 
Hope recorded – using a hidden camera – one man’s 
attempt to get tested for Hepatitis in the Ukraine. Using 
video footage and personal testimonials, the organization 
leveraged mass and social media to help change 
public opinion, reach at-risk populations, and influence 
policymakers. Light of Hope also organized several 
World Hepatitis Day events in Poltava, Ukraine including 
a political rally, HCV media training for activists, and a 
prevention-focused event where social workers provided 

















 ›  In studies conducted in Kenya, South Africa, and Uganda, 
male circumcision was found to lower the risk of HIV 
infection by about 60 percent. In November 2008 the  
Bill & Melinda Gates Foundation provided a five-
year $18.5 million grant to Family Health International 
(FHI) to create the Male Circumcision Consortium 
(MCC), a partnership with the University of Chicago 
and EngenderHealth. The objectives of the MCC are 
to: support the Government of Kenya and other local 
partners to develop and implement a national male 
circumcision strategy, expand a male circumcision 
research and training center in Kisumu, identify and 
address misunderstandings about male circumcision for 
HIV prevention, and conduct research to identify the 
safest and most effective ways to provide voluntary  
male circumcision as part of a comprehensive package  
of HIV prevention services.  
Research and Prevention
 ›  ViiV Healthcare’s Positive Action programme, in 
partnership with the International HIV/AIDS Alliance 
and local community organizations, supports the Vida 
Digna (Life with Dignity) project to address stigma, 
discrimination and violence against key affected and 
vulnerable populations including gay men and other men 
who have sex with men, transgender people, sex workers, 
people who inject drugs, and people living with HIV. This 
is done by monitoring human rights abuses, providing 
technical and legal assistance, and working with national 
authorities to shape policies 
that  protect people living 
with HIV. The project was 
first successful in Mexico 
and then El Salvador, with  
it now being implemented  
in five other Central 
American countries.  
www.aidsalliance.org
Advocacy
A Participant at a Vida Digna 
Workshop ©Atlacatl
The Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping 
their Mothers Alive was launched during the June 2011 United Nations High Level Meeting on AIDS. The 
plan provides the foundation for a country-led movement on the issue. A number of private funders 
are members of the Plan’s Resource Mobilization Workstream, including: the Children’s Investment 
Fund Foundation UK, Elton John AIDS Foundation UK, Johnson & Johnson (J&J), the M•A•C AIDS 
Fund, and Staying Alive Foundation. In July 2012 J&J convened private foundations, corporate funders, 
and bilateral/multilateral agencies to discuss how they can help accelerate the Global Plan. Next steps 
include: exploring a mechanism for funding technical assistance for Global Fund reprogramming and 
renewal; and the further development of a pilot resource mapping effort to highlight progress made 
towards EMTCT and private resources by country. If you are interested in learning more, or participating 
in evolving discussions, please contact: Lauren Marks at lmarks2@its.jnj.com.
Mobilizing Philanthropic Funders for the Global Plan 


















Though the past several years have seen an improvement in prevention of vertical transmission efforts, with the number of children 
newly infected with HIV in 2011 nearly half the number in 2003, there is still a long way to go towards meeting the target of 90% 
coverage by 2015. 
In 2011, only 57% of the estimated 1.5 million pregnant women living with HIV in low- and middle-income countries received 
effective antiretroviral drugs to avoid transmission to the child. Further, less than half of all HIV-positive pregnant women in low- 
and middle-income countries were assessed for their eligibility to receive antiretrovirals for their own health in 2010, and only 31% 
of HIV-positive pregnant women who were eligible for HIV treatment for their own health received it in 2011. And though treatment 
coverage has been increasing for HIV-positive children, only 28% of those in need of antiretroviral therapy received it in 2011.
FINDING THE GAPS: PREVENTION OF VERTICAL 
TRANSMISSION (OR EMTCT)
Sources: UNAIDS. Together We Will End AIDS. 2012.; and UNAIDS. Countdown to Zero: Global Plan Towards the Elimination of New HIV Infections 
Among Children by 2015 and Keeping Their Mothers Alive. 2011. Available at: http://zero-hiv.org/wp-content/uploads/2011/12/GlobalPlan.pdf
Source: UNAIDS. Together We Will End AIDS. 2012.
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on treatment by 2015 (UNGASS goal)
8 million people*
on treatment in 2011
*Over 20% increase from 2012
Treatment Needs in Low- and Middle-Income Countries 
GAP: 7 million 
people
GAP:  26 million people
Though progress has 
been made on delivering 
antiretroviral treatment for 
HIV in low- and middle-
income countries, critical 
gaps remain to reach all 
people in need.
FINDING THE  
GAPS: TREATMENT













Women, youth, and orphans and vulnerable children were the top target populations of HIV/AIDS funding directed to specific 
countries and regions outside of the U.S. 
Chart 12a. Target Populations of U.S. Philanthropic HIV/AIDS Funding for National  
and Regional Work Outside of the U.S. in 2011  (All Top Funders)   
(by percentage of 32 top funders from which target populations data were obtained)
Chart 12b. Top 10 Funders  



















TOP 10: Giving from the top 10 funders of 
national and regional projects outside of 
the U.S. represented 85% of all HIV/AIDS 
philanthropy directed to this category. 






























Percentage of all funders of national and  
regional HIV/AIDS projects outside of the U.S.
Top U.S. HIV/AIDS funders were asked to 
identify the three population groups that 
receive the greatest benefit from their 
funding. The categories are not mutually 
exclusive. (Note: Although funders were 
asked to list only the top three target 
populations of their funding, some reported 
more than three populations. In those  
cases, all populations reported were  
included in Chart 12a.)
Funders who supported medical research 
for national and regional benefit outside 
of the U.S. reported the research targeting 
populations in the East, Southeast Asia  
and Pacific Region.
The “other” category for target populations 
of national and regional funding outside of 
the U.S. included responses that fell outside 
of the pre-determined categories. Funders 
reported examples as “other” such as 
reproductive health care, families, and those 
especially vulnerable to HIV. 
Target Populations of U.S. Philanthropic HIV/AIDS Funding for National and 
Regional Work Outside of the U.S.


















 ›  In June 2011 the M•A•C AIDS Fund committed $2 million 
over the next two years as part of a public-private 
partnership with the U.S. Department of State and 
the South African National Prosecuting Authority 
to expand services for survivors of sexual assault in 
South Africa through the expansion of the Thuthuzela 
Care Network. Statistics show that high rates of HIV 
infection are directly related to the frequency of sexual 
violence in South Africa. The Thuthuzela Care Network 
provides emergency facilities throughout the country 
that provide access to medical, legal and counseling 
services, as well as to HIV testing, prevention and 
treatment programs. With the support of the M•A•C 
AIDS Fund, the partnership will open new clinics in 
rural areas, extend operating hours of existing clinics 
to be accessible at night, and will give victims access to 
the resources they need to take legal action through a 
national prosecuting attorney.
 ›  Forty-five percent of new HIV infections in sub-Saharan 
Africa occur among people under 25 years old, and 
nearly all of them are due to unprotected sex. In 2006, 
the MacArthur Foundation awarded the Abdul Latif 
Jameel Poverty Action Lab (J-PAL) a grant to conduct 
a randomized control trial of HIV prevention strategies. 
In 2011 the Foundation funded J-PAL to expand the 
original study to test the impact of two different HIV 
prevention strategies – voluntary counseling and testing 
for HIV (VCT) and condom distribution – by collecting 
data from 10,000 young people in Kenya. This study 
will examine whether free and easy access to a large 
quantity of condoms can result in a reduction of risky 
behaviors and a decline in transmission of STIs among 
youth. The study will also address gaps in knowledge 
about VCT and condoms. 
 ›  Keep a Child Alive partners with Living India to care for 
60 children living with HIV that have been abandoned 
by their families, often due to the debilitating stigma 
that surrounds people living with HIV/AIDS in India. 
Located in the rural village of Chandrakal, Living India’s 
Home of Hope provides these children with a secure 
living environment, the opportunity to go to school 
(often for the first time), and access to well-balanced 
meals and medical treatment. Keep a Child Alive also 
supports transportation for the HIV-positive children to 
make the monthly three-hour journey to receive their 
antiretroviral medicines. 
 ›  The amfAR GMT Initiative (Gay men, other Men 
who have sex with men, and Transgender individuals 
Initiative, formerly called the MSM Initiative) is a 
small grants program that supports community-based 
efforts to reduce the spread and impact of HIV/AIDS 
among gay men, other men who have sex with men, 
and transgender individuals. One grant to GZTZ.org 
for an internet-based advocacy project focused on 
influencing the GMT internet community in Guangdong 
(China) through the use of MSM storytelling in an effort 
to reduce self-discrimination, stigma, and HIV/STI risk 
behavior and to promote sexual rights and gender 
identity. Another project focused on assessing the 
transgender community in Chengdu (China) with a goal 
of establishing the first formal transgender community-
based organization in China. Since 2007, amfAR’s 
GMT Initiative has awarded more than $3.1 million via 
168 community awards to projects in 69 countries. In 
addition to amfAR, funding for the GMT Initiative comes 
from Aids Fonds, Elton John AIDS Foundation, ViiV 




Orphans and vulnerable children
Men who have sex with men
FUNDING EXAMPLES












 ›  For the past two years, American Jewish World Service 
(AJWS) has provided funding to Women’s Organization 
Network for Human Rights Advocacy (WONETHA) 
in Uganda. WONETHA is a sex worker organization 
that is at the forefront of campaigning for both the 
decriminalization of adult sex work and improving sex 
workers’ access to quality health care, social services 
and safer working conditions. Borne out of the founders’ 
direct experiences of social stigma, harassment, 
violence and arrest, the organization aims to support 
and respect the human rights of all sex workers, 
whether continuing in or leaving the trade. WONETHA 
engages with UNAIDS and national AIDS programs to 
advocate for policy reform, and organizes sex workers 
and brothel owners to promote fair and safe working 
conditions. Grant money has been used to publish a 
peer educators’ guide to sexual and reproductive health. 
Sex workers
The Red Umbrella Fund (RUF) is the first-ever global grantmaking collaborative guided by and for sex 
workers. The fund launched in 2012 to support movements and organizations fighting for sex workers 
health, human and labor rights and self-determination. Hosted by Mama Cash (as administrative host), a 
diverse group of donors including the Open Society Foundations (OSF), Levi Strauss Foundation, Hivos, 
American Jewish World Service (AJWS), the M•A•C AIDS Fund, Comic Relief UK, Oak Foundation, the 
Global Fund for Women, and Aids Fonds participated in and/or funded the process that led to the launch 
of the fund. AJWS, Comic Relief UK, Mama Cash and OSF East Africa currently serve on its International 
Steering Committee. www.redumbrellafund.org.
Launched during AIDS 2012, the Robert Carr civil society Networks Fund helps ensure that civil society 
networks, working at global and regional levels, have sufficient and predictable resources to enhance the 
quality, effectiveness and gender equity of the HIV response, especially in reaching inadequately served 
populations at local level, through global and regional actions. The Carr Fund is overseen by an international 
steering committee bringing together initial donors (expected to be the governments of Norway, the UK 
and US, and the Bill & Melinda Gates Foundation), as well as representatives of civil society networks 
working on AIDS at global and regional levels. www.aidsfonds.nl/rc-nf/robertcarrfund.htm. 
NEW FUND ALERT: The Red Umbrella Fund 
NEW FUND ALERT: The Robert Carr civil society Networks Fund  


















Preliminary UNAIDS data from 95 countries reporting in 2011 suggest that the amount of countries where HIV testing coverage 
has reached 80% for key populations at higher risk is low.
FINDING THE GAPS: KEY POPULATIONS AT HIGHER RISK:  
SEX WORKERS, PEOPLE WHO INJECT DRUGS, AND MEN  
WHO HAVE SEX WITH MEN
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Countries with HIV Testing Coverage at 80% or Greater for Key 
Populations at Higher Risk












Focus on Philanthropic HIV/AIDS Funding with a Global Aim
In an effort to better understand HIV/AIDS 
funding and its impact geographically, a third 
‘global’ geographic section was added to 
the survey tool this year to capture funding 
with a global aim, i.e. funding with more of 
a worldwide reach or target population than 
a specific national or regional impact. (In 
previous years, funders were asked to report 
geographical distribution of their funding 
based on the main office location of the grant 
recipient–either ‘domestic’ grantees within 
the United States or ‘international’ grantees 
outside the United States.) Research grants 
and other projects of benefit to all populations 
worldwide will now be considered ‘global’ 
HIV/AIDS funding.
FCAA identified 12 funders out of the top 69 
funders that disbursed $1 million or more to 
support global AIDS programming in 2011.  
KEY FINDINGS
Projects with a global aim received the majority (44% or $221 million) of all HIV/AIDS disbursements. 
Funder name Global ($) % of total HIV/AIDS  disbursements by funder
Bill & Melinda Gates Foundation, WA 172,000,000 72
Philip T. and Susan M. Ragon Institute Foundation, MA 10,000,000 100
Irene Diamond Fund, NY 7,254,602 100
Open Society Foundations, NY 5,907,049 70
Foundation for the NIH, MD 5,380,944 100
Ford Foundation, NY 4,355,096 23
amfAR, The Foundation for AIDS Research, NY 3,233,975 59
ViiV Healthcare, NC 2,262,879 15
Pfizer Inc, NY 2,235,790 94
The Starr Foundation, NY 2,000,000 80
Doris Duke Charitable Foundation, NY 1,371,000 100
Bristol-Myers Squibb Foundation and Bristol-Myers Squibb Co., NY 1,200,000 13
Table 6: Top U.S. Philanthropic Funders (>$1 Million) of Global HIV/AIDS Work in 2011  (ranked by amount of global disbursements)



















Research projects received nearly all ($186 million) of HIV/AIDS funding with a global aim.
Chart 13a. Intended Use of U.S. Philanthropic HIV/AIDS Funding for Global Work in 2011 (All Funders)
Disbursements (in $ millions) for all funders































FCAA was able to obtain data on intended 
use of global HIV/AIDS grants for 23 of the 24 
top U.S. HIV/AIDS funders of global projects 
in 2011. 
The “other” category for intended use of 
global funding includes funding that was 
unspecified and funding for projects that  
did not fall under the pre-determined 
categories, such as: programmatic and 
planning activities for the International  
AIDS Conference, and organizational 
capacity building.
Intended Use of U.S. Philanthropic HIV/AIDS Funding with a Global Aim
Chart 13b. Funders Other than Gates Foundation






















 ›  In 2011, the Bill & Melinda Gates Foundation granted 
a reported $78.5 million to support preventative HIV 
vaccine research and development, making it the 
second highest funder of HIV vaccine R&D after the 
U.S. Government (including the National Institutes of 
Health [NIH], the U.S. Military HIV Research Program 
[MHRP], and the United States Agency for International 
Development [USAID]). Other research projects 
supported in 2011 by the Gates Foundation included 
$50,000 for therapeutic HIV vaccine R&D, $900,000 for 
HIV cure research, and $7 million for microbicide R&D.
 ›  The Ragon Institute was the sixth largest funder of HIV 
vaccine research and development in 2011. Established 
in 2009 at Massachusetts General Hospital (MGH), 
Massachusetts Institute of Technology (MIT), and Harvard 
University, the Institute was founded by a five-year 
commitment of US$100 million from the Phillip T. and 
Susan M. Ragon Institute Foundation – the largest grant 
in MGH history. The Institute’s launch was an innovative 




(Source: HIV Vaccines & Microbicides Resource Tracking Working Group. Investing to End the AIDS Epidemic: A New Era for HIV Prevention Research & 
Development. July 2012. Available at: http://www.hivresourcetracking.org/content/report-archive)


















Chart 14a.  Target Populations of U.S. Philanthropic HIV/AIDS Funding with a Global Aim in 2011  (All Top Funders)
(by percentage of 22 top funders of global HIV/AIDS projects from which target populations data were obtained)
Percentage of all funders of HIV/AIDS projects with global aim
Percentage of top 10 funders of HIV/AIDS projects with global aim
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Medical research teams and projects, women, men who have sex with men, and youth were the top target populations of HIV/AIDS 
funding with a global aim.
Top U.S. HIV/AIDS funders were asked to 
identify the three population groups that 
receive the greatest benefit from their funding. 
The categories are not mutually exclusive. 
(Note: Although funders were asked to list 
only the top three target populations of their 
funding, some reported more than three 
populations. In those cases, all populations 
reported were included in Chart 14.)
Funders who supported medical research 
for potential global benefit reported the 
research including vaccine research for all 
populations, research on basic HIV science, 
research for uninfected people in developing 
nations, and other projects of potential 
benefit to all population groups worldwide.
The “other” category for target populations 
of global funding included responses that fell 
outside of the pre-determined categories. 
Funders reported examples as “other”  
such as no specific target population,  
HIV/TB prevention and care, and prevention 
of vertical transmission programs for women 
and their families.
Target Populations of U.S. Philanthropic HIV/AIDS Funding with a Global Aim










TOP 10: Giving from the top 10 funders of HIV/AIDS 
projects with a global aim represented 97% of all 
HIV/AIDS philanthropy directed to this category by 
top funders in 2011.




































U.S. and European Philanthropic Support to Address HIV/AIDS in 201150
The Global Fund to Fight AIDS, Tuberculosis 
and Malaria reported contributions of 
approximately $183 million from U.S. and 
European philanthropic funders in 2011. 
Funding for HIV/AIDS through the Global 
Fund was removed from total disbursements 
in this year’s report because it is difficult 
for funders to accurately determine actual 
disbursements to the Global Fund each 
year. The Global Fund accepts donations 
as cash and promissory notes. For example 
in 2011, the Gates Foundation gave a 
$750 million promissory note to the Global 
Fund for a period of 19 years. Under the 
terms of the promissory note, five separate 
annual contributions of $150 million are 
characterized as received for each of the 
years 2011 through 2015 (while actual 
payment of these annual contributions of 
$150 million per year will commence in 2025). 
A part or the full amount of the promissory 
note can be paid earlier, subject to need or 
certain conditions being met.
U.S. and European Philanthropic HIV/AIDS Funding to 
the Global Fund to Fight AIDS, Tuberculosis and Malaria
Global Fund-reported Contributions from U.S. and European Philanthropic and Corporate Donors in 2011 (for all three diseases) 
Funder name $ €
Bill & Melinda Gates Foundation 150,000,000 121,519,802
(PRODUCT) RED™ and Partners [American Express, Apple, Buga-
boo International, Converse, Dell + Windows, GAP, Giorgio Armani, 
Hallmark, Motorola Foundation, Motorola Inc. & Partners, Starbucks 
Coffee, Media Partners and (RED) Supporters]
21,462,249 17,387,255
Chevron Corporation 8,000,000 6,481,056
United Nations Foundation and its donors 2,452,491 1,986,841
Anglo American 1,000,000 810,132
M•A•C AIDS Fund and M•A•C Cosmetics, NY 500,000 405,066
Total $183,414,740 € €148,590,153
















U.S. and European Philanthropic Support to Address HIV/AIDS in 2011 51
Corporations and philanthropies have long played an important role for the Global Fund, both in financial contributions, 
but also in governance, support for advocacy and pro-bono services and partnerships. In this time of resource shortfalls 
for the AIDS response, including at the Global Fund, corporations in particular have launched the kind of new and 
innovative campaigns and collaborations that are needed to increase funding. Here are just a few examples:
 ›  In 2008 FCAA reported on (RED), the economic 
initiative founded in 2006 by philanthropist Bobby 
Shriver and U2 frontman Bono. As a partnership 
between corporations and the Global Fund, (RED) 
leverages the public’s spending power to raise money 
and awareness in the fight against HIV/AIDS in Africa. 
Before (RED) was founded, the Global Fund only 
received 1% of its funding from corporations. In the 
six years since, (RED) has contributed more than $195 
million to support Global Fund grants in Ghana,  
Lesotho, Rwanda, South Africa, Swaziland, and Zambia. 
(RED) delivers these results with a simple mantra: 
“When you DO THE (RED) THING, a (RED) partner will 
give up some of its profits to fight AIDS.” More than 10 
corporate (PRODUCT)RED partners offer hundreds 
of products to choose from in more than 70 countries. 
A portion of product sales then goes directly to the 
Global Fund’s efforts to eliminate AIDS in Africa. Today 
(RED)’s diverse partners include: American Express, 
Apple, Beats by Dr. Dre, Belvedere Vodka, Bugaboo, 
Converse, Nike, Penfolds, and Starbucks, in addition to 
a number of limited edition partners. (RED) is a division 
of The ONE Campaign. 
 ›  The Chevron Corporation became the first Global Fund 
Corporate Champion in 2008, announcing a $30 million 
commitment to the Global Fund at the World Economic 
Forum in Davos, Switzerland. This partnership has 
supported Global Fund grants in Asia and Africa, with 
a focus on capacity development initiatives, advocacy, 
awareness campaigns and workplace wellness initiatives. 
In 2010 Chevron announced an additional $25 million 
commitment, raising its six-year investment in the Global 
Fund to $55 million, making it the largest contribution 
from a single corporation. From 2011 to 2013, Chevron 
is directing this commitment to the U.S. Fund for the 
Global Fund to support programs dedicated to fighting 
HIV/AIDS and reducing vertical transmission of HIV. At 
the International AIDS Conference in July 2012 Chevron 
announced a new partnership initiative with Pact, the 
Business Leadership Council, mothers2mothers and the 
Global Fund to combat vertical transmission in Nigeria, 
Angola and South Africa. The partnership is part of a 
$20 million commitment Chevron made in June 2011 to 
support UNAIDS’ Global Plan Towards the Elimination 
of New HIV Infections Among Children by 2015 and 
Keeping Their Mothers Alive. 
 ›  As this report will show, there are AIDS funders of all 
sizes and priorities. As such, the level of commitment 
demonstrated by the Gates Foundation or Chevron may 
make supporting the Global Fund seem out-of-reach to 
some smaller philanthropic funders. But every dollar 
and action counts. For example, the Open Society 
Foundations Global Health Financing and Health Media 
Initiatives co-funded the July 2012 launch of the Here 
I am Campaign, a global call to save millions of lives by 
supporting a fully funded Global Fund. This new tool 
offers personal testimonials from those directly affected 
by AIDS, tuberculosis, and malaria, as well as a new 
online platform for advocacy mobilization. Take action: 
www.hereiamcampaign.org. 
The Private Sector and The Global Fund
(PRODUCT)RED
Chevron Corporation
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In May 2011 a study from the HIV Prevention 
Trials Network – known as HPTN 05227 
– became the first clinical trial to show 
that treating an HIV-positive person with 
antiretrovirals can reduce the risk of 
sexual transmission of HIV to a negative, 
or uninfected, partner. As these study 
results launched important new debate and 
priorities around the benefits of Treatment 
as Prevention (TasP), in this year’s survey 
FCAA and EFG asked respondents if their 
programming had changed due to new data. 
Several European-based funders noted that 
their programming had not changed, while 
another went further in highlighting that 
access – for both treatment and prevention – 
has always been core to their programming.  
The same responses were collected among 
U.S.-based funders, with many suggesting 
their funding was already supportive of 
TasP, while others are beginning to evaluate 
how their programs might better address 
it. A small number of organizations are also 
supporting their grantees to use their funding 
to facilitate access to TasP for specific 
populations, or are leading conversations on 
TasP within their communities. 
Here are a few specific examples from 
funders in Europe and the U.S.:
  ›  Treatment as prevention has been included 
as a new strategic theme for STOP AIDS 
NOW!. In partnership with the Clinton 
Health Access Initiative (CHAI) and 
with funding from the Dutch National 
Postcode Lottery, STOP AIDS NOW! 
began an ambitious project in Swaziland 
using treatment as prevention called 
‘MaxART- Maximizing ART For Better 
Health and Zero New HIV Infections 
Advocacy.’ The aim of MaxART is for 90% 
of the people in Swaziland requiring HIV 
treatment to receive it before the end of 
2014. It is expected that the number of new 
infections will fall dramatically as a result. 
One goal of the program is to mobilize the 
entire country to know their HIV status and 
regularly seek an HIV test (currently only 
16% of the people in Swaziland ever have 
had a test). People who test positive will 
be linked to care and treated following the 
new World Health Organization guidelines 
for earlier treatment. A special effort will be 
made to ensure people who test positive 
access and remain in treatment and care, 
as the loss to follow-up before being on 
treatment is currently high. Barriers to 
testing and adherence will be researched 
to inform and redirect the program, and 
the needs and realities of people living 
with HIV on the ground will be analyzed 
through existing tools and programs such 
as the People Living with HIV Stigma 
Index, Human Rights Count! and Positive 
Health, Dignity and Prevention. The 
effects (assuming a significant reduction in 
number of new infections) will be modeled 
over a period of 10 years, and a pilot will 
be developed within the program on 
earlier treatment (CD4 count of 500mm3 for 
example or above) than the current World 
Health Organization guidelines to further 
strengthen evidence and practice.
  ›  amfAR’s TREAT Asia Program initiated 
a community education project that is 
being conducted in parallel with a separate 
implementation research study led by the 
Thai Red Cross AIDS Research Center 
(TRCARC) in Bangkok on the test-and-treat 
approach among men who have sex with 
men in three Thai provinces (Bangkok, 
Ubon Ratchathani, and Lampang). The 
study investigators sought opportunities  
to share what is known about test-and-
treat and TasP with local MSM and 
healthcare provider communities in these 
provinces to educate them about the 
potential benefits of earlier treatment as 
well as to promote their study. TREAT Asia 
is now collaborating with the TRCARC 
and Thai provincial AIDS authorities to 
coordinate workshops on the implications 
of test-and-treat and TasP on individuals 
and the community.
  ›  The work of the International 
Treatment Preparedness Coalition 
(ITPC), from inception, has focused on 
treatment literacy, advocacy and services 
through grantmaking. Treatment as 
prevention is a recent scientific finding 
that further highlights the importance 
of treatment preparedness especially for 
discordant couples. ITPC’s programming 
has not changed based on TasP but has 
become even more important. In 2010, 
Open Society Foundations funded 
a grant to support ITPC to develop an 
advocacy agenda for HIV/AIDS advocates 
to participate in research and policy 
initiatives related to the implementation 
of HIV treatment as prevention. This effort 
redoubled OSF’s sense of the need to focus 
on human rights in HIV testing and to 
ensure that human rights remain on the 
TasP agenda.
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U.S. and European Philanthropic Funders and the 
Investment Framework
In 2011, an investment framework, created 
by a group of experts, proposed a strategic 
approach to funding that, if followed, will 
allow millions of additional lives to be saved 
and new infections averted. Respondents 
were also asked if they had realigned their 
funding in light of this new Framework. 
The majority of funders in Europe and the 
U.S. that answered this question indicated 
that their work was already in support of 
aspects of the Investment Framework. In 
addition, two U.S.-based funders of work to 
address the domestic U.S. epidemic provided 
feedback on how their funding is also aligned 
with this global framework. 
Here are a few specific examples from 
funders in Europe and the U.S.:
  ›  Working with and for the community is at 
the core of STOP AIDS NOW!’s work, 
which understands the role of communities 
and that efforts at the community level 
need to be intensified. STOP AIDS NOW!, 
partnering with Aids Fonds and four 
broader development organizations, clearly 
links with broader development sectors, 
such as social protection, education, 
gender equality and health systems.
  ›  Aspects of this framework have been 
addressed by Fondation de France for 
many years now, including improving 
treatment, care and support; prevention 
activities; community mobilization of 
people living with HIV/AIDS; monitoring 
and evaluating approaches to maximize 
impact; and gender equality.
  ›  The Staying Alive Foundation has 
always focused on supporting youth-led 
organizations that lead HIV prevention 
projects among their peers, often from key 
populations at higher risk.
  ›  Cecily’s Fund is concentrating on 
engaging with critical enablers and 
developing synergies between health  
and education in particular. A recent 
grant with Comic Relief UK is aiming 
to involve the local community in the 
strengthening of health and education 
services available for orphans and 
vulnerable children in Kitwe, Zambia. 
  ›  Elton John AIDS Foundation UK 
is increasing its funding towards key 
populations at higher risk, mainly men 
who have sex with men. EJAF UK is also 
committed to the global campaign of 
eliminating vertical transmission by 2015.
  ›  Fondation Total has realigned its funding 
in light of the 2015 Investment Framework. 
The projects reaching out to truck drivers 
about HIV are an example, as they also aim 
to increase awareness of HIV issues among 
sex workers, and provide free condoms 
among other activities. The projects also 
closely work with local communities 
and seek to improve synergies with 
development sectors.
  ›  In 2011, AIDS United launched a 
regional organizing initiative designed to 
mobilize communities on the grassroots 
level, promote a bidirectional exchange 
between national and regional advocacy 
work, and ensure that policy is informed by 
programming on the ground. AIDS United 
also refined the strategic data collection 
of the Community Partnership Challenge 
Grant programming to better capture the 
work in communities across the nation 
focused on strengthening systems for 
health systems improvement.
  ›  Prevention of vertical transmission and 
community engagement and mobilization 
have always been core components of 
the Elizabeth Glaser Pediatric AIDS 
Foundation’s work. 
  ›  In 2011, the AIDS Foundation of 
Chicago (AFC) moved toward giving 
larger, more targeted grants to community 
organizations for greater programmatic 
impact. AFC continues to fund basic 
programming, and has also aligned its local 
grantmaking with two key priority areas 
(seeding and measuring innovation, and 
leading and organizing policy/advocacy 
efforts), dedicating at least 20% of its 
funding to each. The priority populations 
include men who have sex with men, 
people who inject drugs, communities of 
color, women and girls, and individuals and 
families affected by incarceration. Through 
grantmaking and other collaborative efforts 
such as the Service Providers Council, 
AFC strategically connects grantees 
with community leaders, advocates, and 
policymakers. The relationships that result 
from these investments and partnerships 
connect leaders from different sectors in 
unique ways, and further strengthen the 
network of HIV/AIDS services in Chicago 
and statewide. 
  ›  The M•A•C AIDS Fund is now using  
the investment framework as a lens 
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Some organizations working on areas that 
may have an HIV-related component, such 
as sexual and reproductive health and 
rights, global development, maternal and 
child health, or LGBT-related projects, are 
increasingly unable to disaggregate funding 
specifically for HIV. Though some of these 
funders may not appear in the quantitative 
sections of this report, it is important to 
recognize and honor integration of issue 
areas, as these efforts often enhance the 
effectiveness of HIV-related work. Here are  
a few examples:
The United Nations Foundation was 
created in 1998 with entrepreneur and 
philanthropist Ted Turner’s historic $1 billion 
gift to support United Nations causes and 
activities. Its four current areas of focus are: 
energy & climate, global health, the United 
Nations and women & population. The UN 
Foundation hosts (and co-founded with the 
Rockefeller Foundation and the Vodafone 
Foundation) the mHealth Alliance, which 
acts as a convener of the mobile health 
(mHealth) community and seeks to share the 
collective lessons learned and best practices 
developed so that mHealth can continue 
to advance improved health outcomes, 
including through the prevention, diagnosis, 
and treatment of HIV/AIDS.
The Nike Foundation invests exclusively 
in adolescent girls as the most powerful 
force for change and poverty alleviation in 
the developing world. The Foundation’s 
investments are designed to get girls on the 
global agenda and drive resources to them. In 
2008 the Foundation, in partnership with the 
NoVo Foundation, launched the Girl Effect 
(girleffect.org), a bold new communications 
platform that describes, “How the 600 million 
girls in the developing world have the power 
to transform their societies.” The Nike 
Foundation also supports the publication of 
extensive research on adolescent girls, their 
lives, and the critical interventions needed to 
ensure girls reach their potential as economic 
agents of change. Their support of and 
partnership with the Coalition for Adolescent 
Girls has mobilized a new body of research, 
including the Girls Discovered Global Map, 
a new online resource featuring interactive 
data and maps on health (including HIV 
prevalence), education and economic issues 
that help policy makers and donors visualize 
and prioritize investments for girls. 
The William & Flora Hewlett Foundation 
awards grants to help solve social and 
environmental problems in the U.S. and 
abroad. In 2011 the Hewlett Foundation 
supported a Population Action International 
(PAI) project to monitor national budget 
expenditures for reproductive health 
supplies. Among its many roles, PAI 
works to interpret U.S. policies and global 
funding trends for international colleagues. 
Their recent policy brief, Family Planning: 
The Smartest Investment We Can Make, 
outlines the progress and money saved 
through investment in family planning. The 
brief highlights that, “increased access to 
contraception for women in developing 
countries is critical to improving maternal and 
newborn health, preventing HIV/ AIDS, and 
reducing unintended pregnancies and the 
need for abortion.” The Hewlett Foundation 
provides support to organizations like 
International Planned Parenthood Federation 
which provides HIV/AIDS prevention services 
in countries around the world.
Deutsche Stiftung Weltbevoelkerung 
(DSW, or German Foundation for 
World Population) supports integrated 
projects and programs that address sexual 
and reproductive health and rights, family 
planning and HIV prevention in low- and 
middle-income countries. Among DSW’s 
activities is the support and development of 
a network of over 600 youth clubs consisting 
of 30,000 young people in Ethiopia, Kenya, 
Tanzania, and Uganda. As part of the ‘Youth-
to-Youth Initiative,’ (www.youth-to-youth.
org) peer educators at the youth clubs 
provide fellow young people with awareness 
on sexual and reproductive health and 
rights, and prevention of HIV infections and 
unwanted pregnancies. In addition, the peer 
educators help motivate young people to 
overcome their health and financial obstacles 
and create positive change in their own lives 
and communities. An external evaluation 
in 2011 found that the program was 
successfully reaching girls in particular and 
that involvement in the youth clubs helped 
young people increase their self-esteem and 
life skills, including the ability to generate 
income for themselves and their families.
The Paul Rapoport Foundation was 
established in 1987 to serve the lesbian, 
gay, bisexual, and transgender communities 
of the metropolitan New York area. As the 
Foundation plans to spend down its assets 
by 2014, one of its current target populations 
is shared by many HIV/AIDS funders: LGBT 
youth of color. As it has been shown that 
youth are at significantly higher risk for 
engaging in activities such as survival sex 
work if they have no housing options or 
sufficient job training skills, the Foundation 
provided three grants to New York City 
area youth service providers in 2011: to 
support infrastructure development for 
the largest housing provider for homeless 
and runaway LGBT youth of color (some of 
whom are including HIV-positive youth) in 
the country (The Ali Forney Center); provide 
new avenues for career development skills, 
involving nature-based professions, to 
homeless, runaway and foster care LGBT 
youth of color in NYC (Friends of Green 
Chimneys); and to support LGBT youth of 
color in public high schools provide crisis 
intervention to LGBT youth of color on Long 
Island (Long Island Crisis Center). 
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EFG asked funders about their total funding 
commitments in 2011, in addition to their 
actual disbursements. Commitments data 
can be useful for helping to gauge current 
and future outlays. (Disbursements are the 
amount of funding expended on grants/
projects in a given year and may include 
funding from commitments made in 
prior years as well as in the current year. 
Commitments are funding pledged for 
grants/projects in a given year, whether 
or not the funds were paid out in that 
year. For some funders, commitments and 
disbursements are the same in a given  
year; for others, commitments indicate 
funding above or below actual expenditures 
in a year.)
European Philanthropic HIV/AIDS Funding in 2011
KEY FINDINGS
Total funding in 2011: HIV/AIDS disbursements from 38 European-based philanthropies totaled €138 million ($170 million) in 2011, 
amounting to 4,231 HIV/AIDS-related projects and grants.28,29,30
28 This includes data from nine funders in 2011 that were not included in the report on 2010 funding because EFG was not able to obtain their 2010 financial data (eight funders) or 
they were new to funding the HIV/AIDS response (one funder). The others are funders that likely supported HIV/AIDS in 2010 but whose data not available.
29 Funders reported expenditures in various currencies, including euros, U.S. dollars, British pounds, Swedish kronor, and Swiss francs. This necessitated the use of exchange rates; 
the rates used consistently throughout this report were as of 20 August 2012: 1 euro = 1.2343667222 U.S. dollars, 1 euro = 0.7858781189 pounds, 1 euro = 8.2379838281 Swedish 
kronor, and 1 euro = 1.2010335022 Swiss francs.
30 Because this report focuses on capturing relatively specific data on resources provided by the private philanthropy sector only, funders completing the survey were asked 
to exclude income received from any government sources and subsequently re-granted. (Government resource flows are tracked elsewhere; see, for example, www.kff.org/
hivaids/7347.cfm for the latest UNAIDS and Henry J. Kaiser Family Foundation resource tracking of donor governments to HIV/AIDS.)
31 ViiV Healthcare is a specialist HIV company established in November 2009 by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people living with HIV. 
The company has headquarters in both the United States and the United Kingdom and the grantmaking is global in nature. As such, ViiV Healthcare appears in both the European 
and U.S. sections of this report. 
32 Fondazione Cariplo committed a three-year grant in 2009 of €3 million to an HIV/AIDS project in Malawi (Project Malawi), implemented in partnership with the corporation Intesa 
Sanpaolo. One third of that grant is counted here for 2011.
Table 7. European Philanthropic HIV/AIDS Funders in 2011 (ranked by amount of disbursements) 
Funder name
Disbursements Commitments
€ $ € $
1. Wellcome Trust 35,628,934 43,979,171 20,232,145 24,973,886
2. Children's Investment Fund Foundation, UK 19,594,806 24,187,176 23,026,562 28,423,222
3. Sidaction 12,362,452 15,259,799 12,783,466 15,779,485
4. ViiV Healthcare31 11,991,438 14,801,832 11,991,438 14,801,832
5. Elton John AIDS Foundation, UK 10,480,696 12,937,023 12,158,388 15,007,909
6. Comic Relief UK 7,757,768 9,871,464 4,547,241 5,612,963
7. Aids Fonds 5,552,000 6,853,204 6,424,000 7,929,572
8. STOP AIDS NOW! 4,941,000 6,099,006 11,630,000 14,355,685
9. The Monument Trust 4,479,066 5,528,810 3,613,792 4,460,744
10. Nationale Postcode Loterij (Dutch Postcode Lottery) 4,205,000 5,190,512 4,205,000 5,190,512
11. The Diana, Princess of Wales Memorial Fund 3,263,504 4,028,360 1,557,156 1,922,102
12. FXB International (Fondation François-Xavier Bagnoud) 2,603,069 3,213,142 3,482,683 4,298,908
13. AIDS LIFE/Life Ball 2,183,554 2,695,306 2,183,554 2,695,306
14.  Deutsche Stiftung Weltbevölkerung  
(DSW- German Foundation for World Population)
1,905,858 2,352,528 2,201,129 2,717,000
15. VriendenLoterij (Dutch Friends Lottery) 1,825,957 2,323,461 1,825,957 2,253,901
16. Deutsche AIDS-Stiftung 1,637,268 2,020,989 1,690,890 2,087,178
17. Fondation Total 1,347,980 1,663,902 1,347,980 1,663,902
18. Foundation “la Caixa” 1,386,000 1,710,832 1,386,000 1,710,832
19. King Baudouin Foundation 1,328,426 1,639,765 1,006,049 1,241,833
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Note on missing data: A significant 
majority of European private philanthropic 
funding on HIV/AIDS in 2011 has been 
captured in the available data. However,  
EFG was unable to obtain funding data from 
some funders, and they are therefore not 
included in this report. Among them are:
  ›  Anglo American, which made $967,229 
(€673,982) in grants to HIV/AIDS in 2009.
  ›  Esperanza Medicines Foundation, 
which made 555,669 CHF (€485,450) in 
grants to HIV/AIDS in 2009.
  ›  Rush Foundation, founded in September 
2010 to provide immediate support for 
innovative ideas addressing HIV/AIDS and 
its consequences. 
Several other funders that made grants 
towards HIV/AIDS programs in the past are 
not included this year because they did not 
make new grants to HIV/AIDS in 2011. They 
include:
  ›  Big Lottery Fund made £14,084,694 
(€15,969,085) in commitments to HIV/AIDS 
in 2009. That amount was the second 
largest funding amount of all funders in 
2009. No new HIV/AIDS commitments 
were made in 2010 or 2011 from the Big 
Lottery Fund. Though disbursements 
from previous year commitments may 
have been made in 2010 or 2011, that 
information is not available. The prevention 
and mitigation of HIV/AIDS remains a key 
focus area of funding for the Big Lottery 
Fund, and new commitments are likely to 
resume in the future.
Funders new to the report: Table 1 
includes data from eight funders in 2011 
that were not included in the report on 
2010 funding because EFG was not able 
to obtain their 2010 financial data. These 
funders include: Nationale Postcode Loterij 
33 The funding information for HOPEHIV pertains to its 2011 fiscal year, which runs from July 2010 through June 2011. Though EFG asks funders for funding information from the 
previous calendar year (in this case, January through December 2011), the HOPEHIV 2011 fiscal year financial data was the only available data at the time of publication of this 
report.
34 The total for the Sigrid Rausing Trust in 2011 is based on commitments made in 2011, rather than disbursements, as disbursements were not available.
35 Figures for GlaxoSmithKline (GSK) do not include funding from ViiV Healthcare, which is reported separately. In addition, data were not available either in English or otherwise on 
the GSK website for patient group funding grants for the following countries: Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, 
Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Sweden, and Switzerland. It is estimated that this missing data would not exceed €500,000, 
however, as patient groups are a relatively small grants program for GSK.
36 The Staying Alive Foundation, based in the U.S. and the U.K., operated in the U.K. as a registered charity for the first time in 2011. The U.K. program is similar to that of the  
U.S., but currently at a smaller scale. Both programs are included in this report, with the U.S. program in the FCAA section and the separate U.K. program in the EFG section.
37 To avoid double-counting of funds, the 2011 expenditures total reflects a reduction of €4,677,209 ($5,773,391) to correct for re-granting of funds from one EFG-tracked  
funder to another. 
Funder name
Disbursements Commitments
€ $ € $
21. Fondation de France 946,475 1,168,297 1,214,321 1,498,917
22. Fondation Mérieux 722,883 892,303 746,728 921,736
23. HOPEHIV33 712,675 879,703 712,675 879,703
24. Egmont Trust 710,034 876,442 690,400 852,206
25. Oak Foundation 652,258 805,125 276,253 340,998
26. Sigrid Rausing Trust34 578,970 714,662 578,970 714,662
27. Cecily's Fund 578,493 714,073 578,493 714,073
28. One to One Children's Fund 330,840 408,378 330,840 408,378
29. Mama Cash 261,000 322,170 261,000 322,170
30. GlaxoSmithKline35 255,525 315,412 255,525 315,412
31. Swedish Postcode Foundation 242,778 299,677 242,778 299,677
32. Aga Khan Foundation 216,606 267,371 243,040 300,000
33. Aids & Child 216,260 266,944 0 0
34. AVERT 205,853 254,098 205,853 254,098
35. Boehringer Ingelheim 181,000 223,420 181,000 223,420
36. Barry & Martin's Trust 147,477 182,041 147,477 182,041
37. Leverhulme Trust 74,607 92,092 74,607 92,092
38. Staying Alive Foundation36 30,643 37,825 66,228 81,750
Total 2011 European Philanthropic HIV/AIDS Disbursements €€137,861,943
37 
($169,184,702)
Total 2011 European Philanthropic HIV/AIDS Commitments
€€134,099,618 
($164,540,612)
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(Dutch Postcode Lottery), AIDS LIFE/Life 
Ball, Deutsche Stiftung Weltbevölkerung 
(DSW- German Foundation for World 
Population), VriendenLoterij (Dutch 
Friends Lottery), Fondation Total, Swedish 
Postcode Foundation, Boehringer Ingelheim, 
Leverhulme Trust, and Staying Alive 
Foundation. Only one of these funders 
was known to be new to funding the 
HIV/AIDS response in 2011 (Leverhulme 
Trust); the others are funders that likely 
supported HIV/AIDS in 2010 but whose  
2010 data on HIV/AIDS funding was not 
shared or available.















2011 highest funding yet: Among European-based funders for which EFG has five years of comparable data (2007-2011), HIV/AIDS 
disbursements hit the highest point at €108 million ($134 million) in 2011, compared to €84 million ($104 million) in 2007. 
Chart 15.  European Philanthropic HIV/AIDS Funding 2007-2011  
(includes only funders for which five years of data are available)
¤108,481,592
For the 21 of 37 funders for which EFG has 
four years of comparable funding data (2007-
2011), total disbursements in 2011 were 
higher than 2007 – by about €24 million  
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39 Totals for 2010 were recalculated for the set of funders for which both 2010 and 2011 data were available, using the same exchange rates for the 2010 totals as were used for the 
2011 data throughout this report (exchange rate as of 20 August 2012: 1 euro = 1.2343667222 U.S. dollars, 1 euro = 0.7858781189 pounds, and 1 euro = 1.2010335022 Swiss francs).
KEY FINDINGS
Increase from 2010 to 2011 among majority of funders: Total 2011 disbursements increased by 12%, or €14 million ($17 million),39 
among the 27 of 37 funders for which EFG has two years of comparable funding data (2010 and 2011).
It should be noted, however, that several of these funders’ higher totals in 2011 resulted from the pay-out of two years of disbursements in one year,  













Chart 16.  European Philanthropic HIV/AIDS Funding 2010-2011  
(includes only funders for which two years of data are available)
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Concentration of European Philanthropic HIV/AIDS Funders
KEY FINDINGS
Funding highly concentrated among the top 10 funders: The top 10 funders accounted for 82% (€117 million, or $144 million) of all 





Chart 17: Distribution of Funding by European Philanthropic HIV/AIDS Funders in 201140 
(by percentage of total disbursements)
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Just under half of the funders profiled (17 of 38), including six of the top 10 funders, had main offices in the United Kingdom. 
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Forecast for European Philanthropic HIV/AIDS Funding
KEY FINDINGS
2012 forecasted to remain the same: Almost half (44%) of the funders that answered this question (25 of 38) forecast anticipated 
funding for HIV/AIDS would stay about the same in 2012 compared to 2011, including four top 10 funders. 
Several funders, including one top 10 funder, indicated that their HIV/AIDS disbursements would decrease in 2012 due to a shift  
of funds to other related health areas.
Chart 19. Forecast of 2012 European Philanthropic HIV/AIDS Funding41 
(by percentage of funders)
28%
4%
Unsure about  
likely levels
Expect funding to 
decrease in 2012
Includes one top 10 funder
Includes four top 10 funders
Includes two top 10 funders
Includes one top 10 funder
24%
Expect funding to 
increase in 2012
44%
Expect funding to 
remain the same in 2012
41 It should be noted that just over half of the predictions for 2011 funding from the previous year’s survey on 2010 funding were correct (12 of 21 responses). The majority of the 
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Geographic Distribution of European Philanthropic HIV/AIDS Funding
KEY FINDINGS
Majority of funding directed to countries or regions outside of Western and Central Europe, or projects with a global aim targeting 
a worldwide population: Approximately half (52%) of all funding in 201142 was directed to projects in specific countries and regions 
outside of the Western and Central Europe region (€74 million, or $92 million). About a third of all funding (€49 million, or $61 million) 
went to projects benefiting a global population, while €17 million ($21 million), or 12% of all funding in 2011, was expended on HIV/AIDS  
efforts benefiting countries in Western and Central Europe. 
Chart 20. 2011 European Philanthropic HIV/AIDS Funding by Geographic Focus 
(by percentage of total disbursements)





projects with  
a global aim
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EFG identified six funders that expended €1 million or more to HIV/AIDS issues within Western and Central European countries in 2011. 
EFG identified five funders that expended €1 million or more to support HIV/AIDS issues of benefit to a worldwide population in 2011.
Table 8. European Philanthropic HIV/AIDS Funders Allocating €1 million or More to Western and Central European (WCE) 
Countries in 2011
Table 9. European Philanthropic HIV/AIDS Funders Allocating €1 million or More to Work with a Global Aim in 2011
Funder name
Funding to WCE countries
Percent of total giving
€ $
Sidaction 8,214,922 10,140,226 66%
The Monument Trust 2,008,581 2,479,326 45%
Elton John AIDS Foundation, UK 1,824,397 2,251,975 17%
Aids Fonds 1,637,000 2,020,658 29%
Deutsche AIDS-Stiftung 1,215,193 1,499,994 74%
ViiV Healthcare 1,109,768 1,369,861 9%
Funder name
Funding to global projects
Percent of total giving
€ $
Wellcome Trust 35,628,934 43,979,171 100%
Children's Investment Fund Foundation, UK 5,158,192 6,367,101 26%
Aids Fonds 1,983,000 2,447,749 36%
ViiV Healthcare 1,799,435 2,221,163 15%
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Source: UNAIDS. Together We Will End AIDS. 2012.
FINDING THE GAPS: PEOPLE LIVING WITH HIV, NEW INFECTIONS 
AND TREATMENT COVERAGE BY GEOGRAPHIC REGION
Funder name
Funding to global projects
Percent of total giving
€ $
Wellcome Trust 35,628,934 43,979,171 100%
Children's Investment Fund Foundation, UK 5,158,192 6,367,101 26%
Aids Fonds 1,983,000 2,447,749 36%
ViiV Healthcare 1,799,435 2,221,163 15%
Foundation “la Caixa” 1,386,000 1,710,832 100%
KEY FINDINGS
The largest regional recipient of European HIV/AIDS philanthropic funding for countries or regions in 2011 was East and Southern 
Africa (47%), followed by Western and Central Europe (18%). 
Chart 21: Geographical Distribution of National and Regional European Philanthropic HIV/AIDS Funding in 201143
€44,000,434

















43 The category “WCE for outside of WCE region” describes grants made to organizations with their main offices in Western and Central European countries, for work that benefits 
countries outside of that region (such as Africa or Asia). If they were able, funders provided the end recipient countries of those grants (and those countries were considered the 
recipients for the purposes of this chart). However, not all funders know where a grant to a Western or Central European organization working globally will end up being expended—
hence the need for this category, which represented 4% of funding, or €4 million, in 2011. 
(Source: UNAIDS. World AIDS Day Report, 2011. Available at: www.unaids.
org/en/media/unaids/contentassets/documents/unaidspublication/2011/
JC2216_WorldAIDSday_report_2011_en.pdf)
Region People living  with HIV (2010)
New infections 
(2010)
Sub-Saharan Africa 22,900,000(68% of all) 1,900,000
East Asia, Southeast Asia,  
South Asia & the Pacific
4,844,000 361,300
Eastern Europe & Central Asia 1,500,000 160,000
Latin America 1,500,000 100,000
North America 1,300,000 58,000
Western & Central Europe 840,000 30,000
North Africa & the Middle East 470,000 59,000
Caribbean 200,000 12,000
Though treatment coverage 
in the following regions is still 
far from universal, an increase 
in coverage has led to a re-
duction in new HIV infections 
and AIDS-related mortality 
over the past decade.





In regions where HIV infection is 
concentrated among key populations 
at higher risk (people who inject drugs, 
sex workers and men who have sex 
with men), treatment coverage is lower. 
Eastern Europe and Central Asia is 
notable as one of the few regions where 
new HIV infections and AIDS-related 
deaths continue to increase, primarily 
among people who inject drugs who are 
not accessing treatment. 
Treatment coverage in 2011
Asia 44%
Eastern Europe and Central Asia 23% 
North Africa and the Middle East 13%
North Africa & Middle East
South Asia & Pacific
East Asia & Southeast Asia
Unspecified
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The chart below shows the top 20 countries in which European philanthropies supported HIV/AIDS projects in 2011 as well as the total amounts 
provided per country. The majority of the 20 countries are either in Sub-Saharan Africa or Western and Central Europe. 
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 ›  Comic Relief UK awarded a grant to Christian Aid 
and its six local partners in Kenya that aims to fill the 
gaps in government provision by providing a wide, 
integrated range of HIV/AIDS services. This has included 
over 400 support groups for people living with HIV, 
some of which have developed into community-based 
organizations. Beneficiaries are also trained in areas 
such as sustainable agriculture, nutrition, home-based 
care and human rights.
 ›  Through its grant to the Elizabeth Glaser Pediatric 
AIDS Foundation, the Children’s Investment Fund 
Foundation UK (CIFF UK) supports the Government 
of Zimbabwe’s goal to accelerate the scale-up of more 
effective antiretroviral regimens to reduce vertical 
transmission nationally and ensure HIV-positive mothers 
access treatment for their own health and the health 
of their infants. The program’s target is to deliver a 10% 
reduction in the vertical transmission of HIV and results 
so far are on target. CIFF UK has also made a significant 
grant to accelerate the development of in vitro 
diagnostic technology, which is expected to provide 
the world’s first cost-effective point-of-care diagnostic 
testing equipment for pediatric HIV/AIDS. 
 ›  The Nationale Postcode Loterij (Dutch National 
Postcode Lottery) in partnership with UNICEF supports 
a project to help homeless youth in Ukraine and 
Moldova rebuild their lives and return to society. As a 
result of flight from an unsafe home situation, young 
people end up on the streets where they often fall into 
drug use and sex work. In Eastern Europe, where the 
epidemic is growing and is concentrated among people 
who inject drugs, homeless youth are highly vulnerable 
to HIV. UNICEF works with local organizations to help 
provide shelter, medical and psychological care, and 
education to these young people.
 ›  Sidaction supports an internet-based HIV and STD 
prevention program in France reaching out to female, 
gay/MSM and transgender sex workers, who are often 
hard to reach by traditional prevention activities and 
do not access medical or social services due to stigma 
or other barriers. Since public solicitation in France 
was ruled illegal in 2003, the sale of sex through the 
internet has increased considerably. Community-based 
organizations in Lyon and Toulouse provide information 
on sex worker rights, access to healthcare services, 
HIV prevention and harm reduction information and 
incentives for getting tested by being visible on the 
internet via virtual tours and hotlines and specialized 
forums. They also provide legal and social services to 
help mitigate factors that increase the risk of exposure 
to HIV such as violence, isolation and repression.
 ›  Elton John AIDS Foundation UK is supporting 
Kheth’Impilo, a South African NGO that currently 
supports ARV treatment for over 100,000 patients 
within government health clinics, to train pharmacist 
assistants in selected high need rural clinics. South 
Africa’s health system is facing a shortage of skilled 
health care workers that is limiting government’s 
ambitious HIV scale-up program. The grant is helping 
meet a critical human resources gap, and thereby 
increasing access to HIV/TB treatment and services over 
250,000 of patients. The South African government is 
providing stipends for trainees and has guaranteed full 
employment after graduation.
East and Southern Africa
Zimbabwe
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Intended Use of European Philanthropic HIV/AIDS Funding 
KEY FINDINGS
The largest amount of funding went to research (€54 million, or $67 million), followed by prevention (€28 million,  
or $34 million).
Twenty-four funders of 38 provided survey 
data on the intended use of their HIV/AIDS 
grants and projects in 2011. EFG was able 
to gather intended use data in 2011 for 11 
additional funders from annual reports and 
funders’ websites, but could not obtain 
intended use data for three funders. 
The “other” category includes funds from 
organisations that did not disaggregate 
data based on intended use, funding that 
was unspecified, funding that fell under 
multiple categories, or funding for projects 
that did not fall under pre-determined 
categories. Funders reported “other” uses 
such as: a global approach to care of orphans 
and vulnerable children, HIV prevention, 
related social services, and advocacy; 
health systems strengthening; palliative 
care; capacity building; integration of 
sexual and reproductive health services; 
technical assistance; fundraising activities; 
programmatic and planning activities for 
the International AIDS Conference (AIDS 
2012); addressing maternal HIV/AIDS and 
maternal and child health; and scholarships 
for scientific conference attendees. 
Chart 23. Intended Use of European Philanthropic HIV/AIDS Funding in 2011
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 ›  ViiV Healthcare’s Positive Action for Children Fund 
supported Partners in Health’s (PIH) efforts to engage 
pregnant women with health services in some of the 
hardest to reach parts of Lesotho. The country carries 
one of the highest HIV burdens in the world, and the 
socio-economic and socio-political climate leave women 
particularly vulnerable to HIV. Lesotho is also very 
rugged and mountainous, posing obstacles to accessing 
or delivering health services. With the goals of ensuring 
all pregnant women receive HIV testing and deliver their 
babies safely at a clinic with proper HIV treatment if 
necessary, and that health centers provide quality care 
that is accessible to women, PIH’s maternal health and 
HIV project has engaged nurse-midwives to oversee the 
program at local clinics; trained 500 former traditional 
birth attendants to be specialized community health 
workers; created mothers’ waiting houses where women 
can reside up to three weeks prior to delivery; and 
has implemented incentives for mothers to visit health 
clinics, including new baby care and hygiene packages. 
As a result, the number of women receiving more than 
one prenatal care visit at one health clinic increased 
70% in a year.
 ›  Fondation Total supported an HIV prevention project 
for truck drivers, who represent a mobile population 
that can be at high risk for HIV infection. Truck drivers 
can be infected through unprotected sex with a sex 
worker, then transmit HIV returning to a spouse at 
home. Mobile units offering testing, counseling, condoms 
and information were set up where truck drivers were 
known to gather. The project reached over 80,000 
truckers in Morocco and the successful model is now 
being replicated in Cameroon and Burkina Faso.
 ›  Aids Fonds supports local organizations in Eastern 
Europe and Asia that advocate for people living 
with HIV. For example, in Vietnam, brand name 
antiretrovirals are expensive and unaffordable for some 
people living with HIV, while trade agreements made it 
difficult to import much more affordable generic drugs. 
A Vietnamese campaign group supported by Aids 
Fonds fought for relaxation of the import duties on the 
generic antiretrovirals.
 ›  The Wellcome Trust increased its giving toward 
developing an AIDS vaccine in 2011 compared to 2010 
(€5.3 million [$6.5 million] compared to $4.1 million  
[$5.1 million] in 2010) which helped offset a decrease  
in funding for vaccine development from the public 
sector in 2011. 
(Source: HIV Vaccines & Microbicides Resource Tracking Working Group. 
Investing to End the AIDS Epidemic: A New Era for HIV Prevention Research 
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 ›  The Monument Trust gave a grant to the CD4 Initiative, 
managed by the Imperial College London. The project 
forged a successful and innovative industry-focused 
partnership with the diagnostics industry to develop a 
simple, affordable, rapid and robust CD4 point of care 
test designed for resource-poor settings. A CD4 blood 
test counts the number of CD4 T cells of an HIV-positive 
person, and is used to determine when to start treatment. 
Diagnostic instruments however are 
currently expensive, complex, and 
often not available in rural areas 
of resource-poor countries. The 
Monument Trust’s grant is towards 
field trials of the new products. 
 ›  AVERT has been working with Umunthu Foundation, a 
community-based organization in Blantyre, Malawi, since 
2010. HIV and AIDS pose an urgent public health issue 
in this region of Malawi: young people are particularly at 
risk of HIV infection and women are vulnerable due to 
gender inequalities, high levels of gender-based violence 
and their ability to negotiate condom use. Umunthu 
provides comprehensive voluntary counselling and 
testing (VCT) services across three centers, referring 
people who test HIV-positive for treatment, and to 
prevention of vertical transmission services if they are 
pregnant. The project also promotes behavior change 
through innovative HIV prevention activities and works 
to break down stigma and myths around the virus. At 
Umunthu’s offices, support groups for people living with 
HIV and home-based carers meet regularly, and there 
is an open-access sexual health information library. The 
organization has initiated community dialogue with both 
men and women to reduce incidents of gender-based 
violence (GBV) and make the links between violence 
and HIV clearer. The project has a specific focus on 
young people in the community and runs various anti-
AIDS youth groups both in and out of schools to provide 
young people with a platform to talk about HIV and 
sexual health.  In 2011 alone, the project directly reached 
more than 10,000 people from surrounding areas.
Research
Other (Integrated services falling under multiple categories)
Prototype of one new CD4 testing 
device under development
Advocacy funding from philanthropy is especially needed for mobilizing and supporting key populations at higher risk of HIV infection, 
as they are often not supported financially by governments, and often face laws and policies in their countries that act as barriers to 
accessing HIV treatment and care. 
>  Around the world, nearly 80 countries currently have laws that criminalize same-sex sexual relations, which obstructs the 
ability of these individuals to access needed HIV treatment and prevention interventions. 
 
(Source: The International Lesbian, Gay, Bisexual, Trans and Intersex Association (ILGA). State-sponsored Homophobia: A world survey of laws 
criminalizing same-sex sexual acts between consenting adults. May 2012. Available at: old.ilga.org/Statehomophobia/ILGA_State_Sponsored_
Homophobia_2012.pdf)
>  Only an estimated 4% of all HIV-positive people who inject drugs are receiving antiretroviral therapy. Laws and government policies that 
criminalize drug use or do not support access to comprehensive HIV services prevent people who inject drugs from accessing treatment. 
For example, although the number of people living with HIV continues to grow in the Russian Federation where the epidemic is 
largely concentrated among people who inject drugs, the government does not support needle and syringe programs.  
 
(Source: Mathers BM et al. for the UN Reference Group on IDU. “The global epidemiology of injecting drug use and HIV among people who inject drugs: 
A systematic review.” Lancet. 372 [9651]: 1733–1745. 2010.; and Harm Reduction International. The Global State of Harm Reduction 2012: Towards an 
Integrated Response. Available at: www.ihra.net/files/2012/07/24/GlobalState2012_Web.pdf) 
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Target Populations for European Philanthropic HIV/AIDS Funding
EFG was able to obtain information from 
all but one funder on the three population 
groups that receive the greatest benefit from 
their funding. (Some funders reported more 
than three populations as their main focus, 
but they were asked to list only the top three 
target populations of their funding.) The 
categories are not mutually exclusive.
Funders who supported medical research 
reported the research targeting populations 
including mothers and children, pregnant 
women, children, people living with HIV, 
uninfected people, and women living with 
HIV of childbearing age.
The “other” category includes populations 
that did not fit elsewhere. For example, 
funders reported people in need of palliative 
care, Ministries of Health, truck drivers, 
mothers and babies, and transgender and 
transsexual people as “other.”
KEY FINDINGS
The top three target populations of funding in 2011 were orphans and vulnerable children, youth, and women.
10% 20% 30% 40% 50% 60%
Men who have sex with men
Health care workers
People who inject drugs
Other
Medical research
Orphans and vulnerable children
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HIV is the leading cause of death for women of reproductive age worldwide, yet, of 170 countries, over half (59%) of these governments 
did not have an HIV strategy or an earmarked budget that specifically included and addressed women. Women and girls can be 
disproportionately vulnerable to HIV infection due to their lower social and economic status than men in many cultures, and gender-
based violence has been linked to an increased risk of HIV. 
 
(Source: World Health Organization. Women and health: today’s evidence, tomorrow’s agenda. 2009. Available at: www.who.int/gender/women_health_
report/en/index.html; and UNAIDS, NCPI [National Commitments and Policy Instrument] data, government reporting, from 2012 country reports.)
FINDING THE GAPS: SPECIFIC NEEDS OF WOMEN
 ›  Cecily’s Fund commissioned an external impact 
assessment of its program that provides 50% of 
school fees for orphans and vulnerable children in 
Kitwe, Zambia. The assessment found that while the 
program was urgently needed, many families struggled 
to generate the remaining 50% of school fees, and 
that the education system in Zambia was failing to 
prepare students for entrepreneurship and economic 
self-reliance once they had graduated from school. 
As a result, Cecily’s Fund and local partners are using 
this learning to strengthen local communities’ ability 
to advocate more effectively for better support and 
services for orphans and vulnerable children, and 
exploring opportunities for linking with providers who 
can help improve the training available for post-school 
employment opportunities. 
 ›  STOP AIDS NOW! in partnership with Rutgers WPF, a Dutch organization that works for sexual and reproductive 
health and rights (SRHR), is training a pool of trainers in Ethiopia, Kenya, Nigeria and Zimbabwe to improve SRHR 
and HIV prevention programs for youth. The program uses the Evidence & Rights-based Planning & Support Tool 
created by STOP AIDS NOW! as a starting point. After completing the training, the participants are ready to 
improve their own programs for youths as well as to teach other organizations to work with the tool.
Orphans and vulnerable children
Youth
FUNDING EXAMPLES
Cecily’s Fund-supported children at Ndeke High School in Kitwe, Zambia
 ›  Fondation de France supported a project in the Democratic Republic 
of Congo in a region heavily affected by ethnic conflict and sexual 
violence. The project helps women that have been victims of rape 
receive medical and psychological care, HIV testing and treatment, 
and other services to assist them in healing. The project also reaches 
out to male partners of rape victims (husbands who were often 
choosing to neglect or reject a raped wife) and works to change the 
attitudes and rebuild the marital relationships. The project also aims 
to make the community aware of the need to end gender-based 
violence and promote a more positive image of women. 
Women
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